Laure Gossec
#122,017
Most Influential Person Now
Researcher
Laure Gossec's AcademicInfluence.com Rankings
Laure Gosseccomputer-science Degrees
Computer Science
#4967
World Rank
#5246
Historical Rank
Machine Learning
#1150
World Rank
#1170
Historical Rank
Artificial Intelligence
#1380
World Rank
#1408
Historical Rank
Database
#2137
World Rank
#2248
Historical Rank
Download Badge
Computer Science
Laure Gossec's Degrees
- PhD Computer Science Université Paris Cité
- Masters Computer Science Université Paris Cité
Similar Degrees You Can Earn
Why Is Laure Gossec Influential?
(Suggest an Edit or Addition)Laure Gossec's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs (2010) (4048)
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update (2010) (2474)
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update (2013) (1711)
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update (2020) (1453)
- Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry (2020) (867)
- European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update (2015) (854)
- Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0. (2014) (637)
- Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review (2005) (507)
- Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis (2014) (499)
- European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies (2011) (477)
- Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force (2017) (476)
- Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials (2008) (458)
- Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry (2021) (446)
- Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force (2013) (436)
- EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update (2020) (433)
- Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis (2010) (358)
- Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis (2014) (286)
- Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review (2007) (279)
- A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative (2014) (277)
- EULAR recommendations for patient education for people with inflammatory arthritis (2015) (261)
- A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis (2011) (261)
- Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis. (2013) (239)
- Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative (2011) (234)
- European League Against Rheumatism recommendations for the inclusion of patient representatives in scientific projects (2011) (226)
- QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries (2007) (223)
- Influence of adipokines and ghrelin on bone mineral density and fracture risk: a systematic review and meta-analysis. (2011) (220)
- Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study (2006) (219)
- Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative (2008) (210)
- EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2 (2020) (208)
- Cardiovascular profile in ankylosing spondylitis: A systematic review and meta‐analysis (2011) (207)
- Infections during tumour necrosis factor-alpha blocker therapy for rheumatic diseases in daily practice: a systematic retrospective study of 709 patients. (2006) (189)
- Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries (2020) (185)
- Efficacy of cardiorespiratory aerobic exercise in rheumatoid arthritis: Meta‐analysis of randomized controlled trials (2010) (183)
- International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials (2016) (175)
- Efficacy and safety of steroid injections for shoulder and elbow tendonitis: a meta-analysis of randomised controlled trials (2008) (174)
- Reporting of patient-reported outcomes in recent trials in rheumatoid arthritis: a systematic literature review (2008) (171)
- Pigmented villonodular synovitis: a retrospective single-center study of 122 cases and review of the literature. (2011) (169)
- The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacement. (2011) (168)
- Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative (2016) (167)
- Cross-cultural adaptation and validation of the French version of the Knee injury and Osteoarthritis Outcome Score (KOOS) in knee osteoarthritis patients. (2008) (166)
- Efficacy and safety of opioids for osteoarthritis: a meta-analysis of randomized controlled trials. (2007) (162)
- Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature (2016) (159)
- Determinants of discordance in patients' and physicians' rating of rheumatoid arthritis disease activity (2012) (158)
- Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis (2014) (149)
- The Prevalence of Osteoporosis, Osteopenia, and Fractures Among Adults with Cystic Fibrosis: A Systematic Literature Review with Meta-Analysis (2009) (144)
- Sensitivity and specificity of the American College of Rheumatology 1987 criteria for the diagnosis of rheumatoid arthritis according to disease duration: a systematic literature review and meta-analysis (2008) (142)
- Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion. (2006) (134)
- Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study (2004) (134)
- Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry (2021) (131)
- Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA) (2014) (129)
- Recommendations of the French Society for Rheumatology for managing rheumatoid arthritis. (2014) (128)
- Radiological damage in patients with rheumatoid arthritis on sustained remission (2006) (128)
- Gait analysis as a quantifiable outcome measure in hip or knee osteoarthritis: a systematic review. (2010) (128)
- Increase in Vertebral Fracture Risk in Postmenopausal Women Using Omeprazole (2008) (126)
- Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey. (2013) (126)
- Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatment. (2008) (125)
- Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor alpha blockers. (2007) (119)
- Pharmacological treatment of psoriatic arthritis: a systematic literature review for the 2015 update of the EULAR recommendations for the management of psoriatic arthritis (2015) (105)
- OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. (2007) (104)
- Comparative evaluation of three semi-quantitative radiographic grading techniques for knee osteoarthritis in terms of validity and reproducibility in 1759 X-rays: report of the OARSI-OMERACT task force. (2008) (104)
- Quality of life in psoriatic arthritis (2018) (99)
- Comparative study of MRI and power Doppler ultrasonography of the heel in patients with spondyloarthritis with and without heel pain and in controls (2011) (95)
- Treating rheumatoid arthritis to target: the patient version of the international recommendations (2011) (94)
- Cardiovascular risk and rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion. (2006) (93)
- Pharmacological treatment of psoriatic arthritis: a systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritis (2016) (90)
- Reliability of ultrasonography to detect synovitis in rheumatoid arthritis: A systematic literature review of 35 studies (1,415 patients) (2010) (90)
- Clinical relevance of C-reactive protein in ankylosing spondylitis and evaluation of the NSAIDs/coxibs' treatment effect on C-reactive protein. (2010) (87)
- Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016 (2017) (86)
- Disease activity score-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis: data from the GUEPARD trial and ESPOIR cohort (2011) (86)
- Patient-reported outcomes as end points in clinical trials in rheumatoid arthritis (2015) (86)
- Retention rates of tumor necrosis factor blockers in daily practice in 770 rheumatic patients. (2006) (83)
- Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: Results from the Autoimmunity and Rituximab Registry (2012) (83)
- Management of psoriatic arthritis in 2016: a comparison of EULAR and GRAPPA recommendations (2016) (82)
- Reporting of Adherence to Medication in Recent Randomized Controlled Trials of 6 Chronic Diseases: A Systematic Literature Review (2007) (81)
- Serious infections in patients with ankylosing spondylitis with and without TNF blockers: a systematic review and meta-analysis of randomised placebo-controlled trials (2009) (81)
- Detection of Flares by Decrease in Physical Activity, Collected Using Wearable Activity Trackers in Rheumatoid Arthritis or Axial Spondyloarthritis: An Application of Machine Learning Analyses in Rheumatology (2019) (81)
- How to Choose Core Outcome Measurement Sets for Clinical Trials: OMERACT 11 Approves Filter 2.0 (2014) (81)
- Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry (2021) (79)
- OARSI/OMERACT Initiative to Define States of Severity and Indication for Joint Replacement in Hip and Knee Osteoarthritis. An OMERACT 10 Special Interest Group (2011) (77)
- Vertebral dimensions as risk factor of vertebral fracture in osteoporotic patients: a systematic literature review (2007) (77)
- Secukinumab improves patient-reported outcomes in subjects with active psoriatic arthritis: results from a randomised phase III trial (FUTURE 1) (2016) (76)
- Concomitant therapy: an outcome variable for musculoskeletal disorders? Part 2: total joint replacement in osteoarthritis trials. (2001) (75)
- Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control study (2010) (74)
- Suppressing Inflammation in Rheumatoid Arthritis: Does Patient Global Assessment Blur the Target? A Practice‐Based Call for a Paradigm Change (2018) (74)
- OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention Studies (2019) (73)
- Drivers of patient global assessment in patients with rheumatoid arthritis who are close to remission: an analysis of 1588 patients (2017) (72)
- The impact of coping strategies on mental and physical well-being in patients with rheumatoid arthritis. (2012) (71)
- Nonpharmacological treatments in early rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion. (2006) (71)
- Cross-cultural adaptation and validation of the French version of the Hip disability and Osteoarthritis Outcome Score (HOOS) in hip osteoarthritis patients. (2010) (71)
- Update of French society for rheumatology recommendations for managing rheumatoid arthritis. (2019) (69)
- TNF alpha antagonist therapy and safety monitoring. (2011) (68)
- 2018 update of French Society for Rheumatology (SFR) recommendations about the everyday management of patients with spondyloarthritis. (2018) (68)
- Validation of a numerical rating scale to assess functional impairment in hip and knee osteoarthritis: comparison with the WOMAC function scale (2010) (67)
- Patient‐Physician Discordance in Global Assessment in Rheumatoid Arthritis: A Systematic Literature Review With Meta‐Analysis (2016) (67)
- Research in hand osteoarthritis: time for reappraisal and demand for new strategies. An opinion paper (2007) (66)
- Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers’ effectiveness in axial spondyloarthritis: results of a prospective, multicentre study (2017) (66)
- Defining cut-off values for disease activity states and improvement scores for patient-reported outcomes: the example of the Rheumatoid Arthritis Impact of Disease (RAID) (2012) (65)
- The patient perspective on absence of disease activity in rheumatoid arthritis: a survey to identify key domains of patient-perceived remission (2015) (65)
- The impact of chronic low back pain is partly related to loss of social role: A qualitative study. (2014) (64)
- Mobile Health Apps for Self-Management of Rheumatic and Musculoskeletal Diseases: Systematic Literature Review (2019) (64)
- Classification criteria for rheumatic diseases: why and how? (2007) (64)
- Efficacy of cyclo-oxygenase-2 inhibition by etoricoxib and naproxen on the axial manifestations of ankylosing spondylitis in the presence of peripheral arthritis (2005) (62)
- EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases (2019) (62)
- Patient participation as an integral part of patient-reported outcomes development ensures the representation of the patient voice: a case study from the field of rheumatology (2015) (62)
- Minimal Disease Activity as a Treatment Target in Psoriatic Arthritis: A Review of the Literature (2018) (61)
- Patient's global assessment of disease activity and patient's assessment of general health for rheumatoid arthritis activity assessment: are they equivalent? (2012) (61)
- New GRAPPA and EULAR recommendations for the management of psoriatic arthritis. (2017) (60)
- Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial (2020) (60)
- Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries (2018) (60)
- Reevaluation of the Role of Duration of Morning Stiffness in the Assessment of Rheumatoid Arthritis Activity (2009) (59)
- The association of fatigue, comorbidity burden, disease activity, disability and gross domestic product in patients with rheumatoid arthritis. Results from 34 countries participating in the Quest-RA program. (2014) (59)
- Clinical relevance of switching to a second tumour necrosis factor-alpha inhibitor after discontinuation of a first tumour necrosis factor-alpha inhibitor in rheumatoid arthritis: a systematic literature review and meta-analysis. (2011) (59)
- Abatacept therapy and safety management. (2009) (59)
- Reliability of joint count assessment in rheumatoid arthritis: a systematic literature review. (2014) (58)
- Which variables best predict change in rheumatoid arthritis therapy in daily clinical practice? (2006) (58)
- Adaptation and cross-cultural validation of the rheumatoid arthritis work instability scale (RA–WIS) (2008) (57)
- Evaluation of Serum Interleukin‐6 Level as a Surrogate Marker of Synovial Inflammation and as a Factor of Structural Progression in Early Rheumatoid Arthritis: Results From a French National Multicenter Cohort (2015) (57)
- Intra-articular treatments in osteoarthritis: from the symptomatic to the structure modifying (2004) (57)
- Tocilizumab: therapy and safety management. (2010) (56)
- Combinatorial control of Th17 and Th1 cell functions by genetic variations in genes associated with the interleukin-23 signaling pathway in spondyloarthritis. (2013) (55)
- Updating the OMERACT Filter: Implications for Patient-reported Outcomes (2014) (55)
- Promoting patient‐centred care in psoriatic arthritis: a multidisciplinary European perspective on improving the patient experience (2015) (55)
- Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’’ by Mulhearn et al (2021) (55)
- Clinical outcomes in psoriatic arthritis: A systematic literature review (2012) (54)
- Psychometric properties of the OARSI/OMERACT osteoarthritis pain and functional impairment scales: ICOAP, KOOS-PS and HOOS-PS. (2011) (53)
- Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis (2019) (53)
- Diagnostic delay in axial spondyloarthritis: A cross-sectional study of 432 patients. (2016) (53)
- Reliability of patient self‐evaluation of swollen and tender joints in rheumatoid arthritis: A comparison study with ultrasonography, physician, and nurse assessments (2010) (52)
- Predictive factors of total hip replacement due to primary osteoarthritis: a prospective 2 year study of 505 patients (2005) (51)
- Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology (2019) (50)
- EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseases (2019) (50)
- 2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis (2018) (50)
- Determinants of Patient‐Physician Discordance in Global Assessment in Psoriatic Arthritis: A Multicenter European Study (2017) (50)
- EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update (2022) (50)
- Limited Value of Temporal Artery Ultrasonography Examinations for Diagnosis of Giant Cell Arteritis: Analysis of 77 Subjects (2010) (50)
- Physical examination and laboratory tests in the management of patients with rheumatoid arthritis: development of recommendations for clinical practice based on published evidence and expert opinion. (2005) (49)
- Use of Wearable Activity Trackers to Improve Physical Activity Behavior in Patients With Rheumatic and Musculoskeletal Diseases: A Systematic Review and Meta‐Analysis (2019) (48)
- A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative. (2017) (48)
- Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT Methodology (2019) (48)
- Influence of flare design on symptomatic efficacy of non-steroidal anti-inflammatory drugs in osteoarthritis: a meta-analysis of randomized placebo-controlled trials. (2010) (47)
- The European Map of Axial Spondyloarthritis: Capturing the Patient Perspective—an Analysis of 2846 Patients Across 13 Countries (2019) (47)
- Fatigue in psoriatic arthritis - a cross-sectional study of 246 patients from 13 countries. (2016) (46)
- Dissemination and evaluation of the ASAS/EULAR recommendations for the management of ankylosing spondylitis: results of a study among 1507 rheumatologists (2007) (45)
- Role and modalities of information and education in the management of patients with rheumatoid arthritis: development of recommendations for clinical practice based on published evidence and expert opinion. (2005) (44)
- An Assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDAS (2017) (43)
- Rituximab therapy in rheumatoid arthritis in daily practice. (2008) (43)
- Recommendations for the Involvement of Patient Research Partners (PRP) in OMERACT Working Groups. A Report from the OMERACT 2014 Working Group on PRP (2016) (43)
- Rheumatic and Musculoskeletal Features of Whipple Disease: A Report of 29 Cases (2013) (43)
- An e-health interactive self-assessment website (Sanoia®) in rheumatoid arthritis. A 12-month randomized controlled trial in 320 patients. (2017) (43)
- International Consortium for Health Outcome Measurement Set of Outcomes That Matter to People Living With Inflammatory Arthritis: Consensus From an International Working Group (2019) (42)
- OARSI-OMERACT initiative: defining thresholds for symptomatic severity and structural changes in disease modifying osteoarthritis drug (DMOAD) clinical trials. (2012) (42)
- Influence of sex on disease severity in patients with rheumatoid arthritis. (2005) (41)
- In wealthier countries, patients perceive worse impact of the disease although they have lower objectively assessed disease activity: results from the cross-sectional COMORA study (2015) (41)
- Physical Activity Assessment Using an Activity Tracker in Patients with Rheumatoid Arthritis and Axial Spondyloarthritis: Prospective Observational Study (2018) (41)
- Challenges of Cardiovascular Risk Assessment in the Routine Rheumatology Outpatient Setting: An Observational Study of 110 Rheumatoid Arthritis Patients (2013) (40)
- Comparative evaluation of three semi-quantitative radiographic grading techniques for hip osteoarthritis in terms of validity and reproducibility in 1404 radiographs: report of the OARSI-OMERACT Task Force. (2009) (40)
- Successful Stepwise Development of Patient Research Partnership: 14 Years’ Experience of Actions and Consequences in Outcome Measures in Rheumatology (OMERACT) (2016) (40)
- The Reporting of Patient-reported Outcomes in Studies of Patients with Rheumatoid Arthritis: A Systematic Review of 250 Articles (2016) (40)
- Preliminary definitions of ‘flare’ in axial spondyloarthritis, based on pain, BASDAI and ASDAS-CRP: an ASAS initiative (2015) (39)
- PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials (2018) (38)
- Improving the Management of Psoriatic Arthritis and Axial Spondyloarthritis: Roundtable Discussions with Healthcare Professionals and Patients (2017) (37)
- Structural evaluation in the management of patients with rheumatoid arthritis: development of recommendations for clinical practice based on published evidence and expert opinion. (2005) (37)
- Updating the OMERACT Filter: Implications of Filter 2.0 to Select Outcome Instruments Through Assessment of “Truth”: Content, Face, and Construct Validity (2014) (36)
- Intra-articular injections in thumb osteoarthritis: A systematic review and meta-analysis of randomized controlled trials. (2015) (36)
- New tools for diagnosing spondyloarthropathy. (2010) (36)
- Enhanced Patient Involvement and the Need to Revise the Core Set — Report from the Psoriatic Arthritis Working Group at OMERACT 2014 (2015) (36)
- Fatigue in rheumatoid arthritis: quantitative findings on the efficacy of tocilizumab and on factors associated with fatigue. The French multicentre prospective PEPS Study. (2015) (35)
- Patient Involvement in Outcome Measures for Psoriatic Arthritis (2014) (35)
- Methods to improve medication adherence in patients with chronic inflammatory rheumatic diseases: a systematic literature review (2018) (35)
- Relationship between optimism and quality of life in patients with two chronic rheumatic diseases: axial spondyloarthritis and chronic low back pain: a cross sectional study of 288 patients (2015) (35)
- OP0004 Collection and Management of Selected Comorbidities and Their Risk Factors in Chronic Inflammatory Rheumatic Diseases in Daily Practice in France (2016) (34)
- Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis (2018) (34)
- Characteristics and Outcomes of People With Gout Hospitalized Due to COVID‐19: Data From the COVID‐19 Global Rheumatology Alliance Physician‐Reported Registry (2022) (34)
- Cost-effectiveness modelling of biological treatment sequences in moderate to severe rheumatoid arthritis in France. (2010) (34)
- OARSI/OMERACT Criteria of Being Considered a Candidate for Total Joint Replacement in Knee/Hip Osteoarthritis as an Endpoint in Clinical Trials Evaluating Potential Disease Modifying Osteoarthritic Drugs (2009) (34)
- Recommendations for the assessment and optimization of adherence to disease-modifying drugs in chronic inflammatory rheumatic diseases: A process based on literature reviews and expert consensus. (2019) (33)
- Validity and responsiveness of radiographic joint space width metric measurement in hip osteoarthritis: a systematic review. (2011) (33)
- What are the best markers for disease progression in osteoarthritis (OA)? (2010) (33)
- Risk of infections in bronchiectasis during disease-modifying treatment and biologics for rheumatic diseases (2011) (33)
- Measuring impairments of functioning and health in patients with axial spondyloarthritis by using the ASAS Health Index and the Environmental Item Set: translation and cross-cultural adaptation into 15 languages (2016) (32)
- Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial (2021) (32)
- Dual target strategy: a proposal to mitigate the risk of overtreatment and enhance patient satisfaction in rheumatoid arthritis (2018) (32)
- Combination therapy for early rheumatoid arthritis (2003) (32)
- Patient global assessment in psoriatic arthritis - what does it mean? An analysis of 223 patients from the Psoriatic arthritis impact of disease (PsAID) study. (2016) (31)
- Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases (2021) (31)
- In rheumatoid arthritis, country of residence has an important influence on fatigue: results from the multinational COMORA study. (2016) (30)
- Minimal Disease Activity Among Active Psoriatic Arthritis Patients Treated With Secukinumab: 2‐Year Results From a Multicenter, Randomized, Double‐Blind, Parallel‐Group, Placebo‐Controlled Phase III Study (2018) (30)
- Prevalence and characteristics of hip involvement in spondyloarthritis: a single-centre observational study of 275 patients. (2012) (30)
- Why should rheumatologists evaluate the impact of rheumatoid arthritis on sexuality? (2010) (29)
- Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study (2018) (29)
- Safety of biologics: elaboration and validation of a questionnaire assessing patients' self-care safety skills: the BioSecure questionnaire. An initiative of the French Rheumatology Society Therapeutic Education section. (2013) (29)
- Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’’ by Rosenbaum et al (2021) (28)
- Outcome Domains and Measures in Total Joint Replacement Clinical Trials: Can We Harmonize Them? An OMERACT Collaborative Initiative (2015) (28)
- Glucocorticoid sparing effect of tumour necrosis factor alpha inhibitors in rheumatoid arthritis in real life practice. (2009) (28)
- The revised Bristol Rheumatoid Arthritis Fatigue measures and the Rheumatoid Arthritis Impact of Disease scale: validation in six countries (2017) (28)
- Determinants of Patient‐Reported Psoriatic Arthritis Impact of Disease: An Analysis of the Association With Sex in 458 Patients From Fourteen Countries (2020) (28)
- Smokers and non smokers with rheumatoid arthritis have similar clinical status: data from the multinational QUEST-RA database. (2010) (28)
- The EULAR Outcome Measures Library: an evolutional database of validated patient-reported instruments (2014) (28)
- Revisiting the use of remission criteria for rheumatoid arthritis by excluding patient global assessment: an individual meta-analysis of 5792 patients (2020) (28)
- Physical activity in patients with axial spondyloarthritis: a cross-sectional study of 203 patients (2016) (27)
- Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting (2016) (26)
- Ability of disease-modifying antirheumatic drugs to prevent or delay rheumatoid arthritis onset: a systematic literature review and meta-analysis (2018) (25)
- Relative Clinical Influence of Clinical, Laboratory, and Radiological Investigations in Early Arthritis on the Diagnosis of Rheumatoid Arthritis. Data from the French Early Arthritis Cohort ESPOIR (2010) (25)
- Reporting of patient-perceived impact of rheumatoid arthritis and axial spondyloarthritis over 10 years: a systematic literature review (2014) (25)
- Prevalence of degenerative changes and overlap with spondyloarthritis-associated lesions in the spine of patients from the DESIR cohort (2018) (25)
- Needs, Experiences, and Views of People With Rheumatic and Musculoskeletal Diseases on Self-Management Mobile Health Apps: Mixed Methods Study (2020) (25)
- Patient-physician discordance in global assessment in early spondyloarthritis and its change over time: the DESIR cohort (2015) (25)
- Impact of comorbidities on fatigue in rheumatoid arthritis patients: Results from a nurse-led program for comorbidities management (COMEDRA). (2019) (25)
- C-reactive protein predicts tumor necrosis factor-alpha blocker retention rate in axial ankylosing spondylitis. (2007) (24)
- Associations Between Five Important Domains of Health and the Patient Acceptable Symptom State in Rheumatoid Arthritis and Psoriatic Arthritis: A Cross‐Sectional Study of 977 Patients (2017) (24)
- 2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and musculoskeletal diseases for use in clinical practice (2020) (24)
- When and for how long should glucocorticoids be used in rheumatoid arthritis? International guidelines and recommendations (2014) (24)
- How COVID-19 is changing rheumatology clinical practice (2020) (24)
- Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study (2021) (23)
- Flares assessed weekly in patients with rheumatoid arthritis or axial spondyloarthritis and relationship with physical activity measured using a connected activity tracker: a 3-month study (2017) (23)
- SARS-CoV-2 infection after vaccination in patients with inflammatory rheumatic and musculoskeletal diseases (2021) (23)
- Direct Cost-Modeling of Rheumatoid Arthritis According to Disease Activity Categories in France (2011) (23)
- Do intra-articular therapies work and who will benefit most? (2006) (23)
- Abatacept therapy and safety management. (2012) (23)
- Factors associated with the orthopaedic surgeon's decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1905 patients. (2018) (23)
- Fears and beliefs of people living with rheumatoid arthritis: a systematic literature review (2018) (23)
- Response to: ‘Comment on: ‘EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update’ by Gossec et al’ by Wei et al (2020) (22)
- Updating the OMERACT Filter: Core Areas as a Basis for Defining Core Outcome Sets (2014) (22)
- Engaging Stakeholders and Promoting Uptake of OMERACT Core Outcome Instrument Sets (2017) (22)
- Clinical characteristics of anterior chest wall pain in spondyloarthritis: an analysis of 275 patients. (2012) (22)
- Prevalence of Renal Impairment in Patients With Rheumatoid Arthritis: Results From a Cross‐Sectional Multicenter Study (2015) (22)
- Prevalence and clinical characteristics of dactylitis in spondylarthritis: a descriptive analysis of 275 patients. (2012) (22)
- Acute anterior uveitis in spondyloarthritis: a monocentric study of 301 patients. (2019) (21)
- Assessment of work instability in spondyloarthritis: a cross-sectional study using the ankylosing spondylitis work instability scale. (2012) (21)
- Comparison of the clinical characteristics of vasculitis occurring during anti-tumor necrosis factor treatment or not in rheumatoid arthritis patients. A systematic review of 2707 patients, 18 vasculitis. (2008) (21)
- Effect of biologics on fatigue in psoriatic arthritis: A systematic literature review with meta-analysis. (2018) (21)
- Disease activity trajectories in early axial spondyloarthritis: results from the DESIR cohort (2015) (21)
- Mapping the Effect of Psoriatic Arthritis Using the International Classification of Functioning, Disability and Health (2017) (21)
- How are enthesitis, dactylitis and nail involvement measured and reported in recent clinical trials of psoriatic arthritis? A systematic literature review (2017) (20)
- Recommandations de la Société francaise de rhumatologie pour la prise en charge de la polyarthrite rhumatoïde (2014) (20)
- Elaboration and validation of a questionnaire (Qualisex) to assess the impact of rheumatoid arthritis on sexuality with patient involvement. (2012) (20)
- OP0235 SECUKINUMAB IMPROVES AXIAL MANIFESTATIONS IN PATIENTS WITH PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO NSAIDS: PRIMARY ANALYSIS OF THE MAXIMISE TRIAL (2019) (20)
- Performance of the Assessment in Spondyloarthritis International Society Classification for Axial and Peripheral Spondyloarthritis in an Established Clinical Cohort: Comparison with Criteria Sets of Amor and the European Spondylarthropathy Study Group (2012) (20)
- Updating the OMERACT Filter: Discrimination and Feasibility (2014) (20)
- Updating the OMERACT Filter: Implications for Imaging and Soluble Biomarkers (2014) (20)
- SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry (2022) (20)
- Leflunomide in rheumatoid arthritis in daily practice: treatment discontinuation rates in comparison with other DMARDs. (2006) (20)
- LB0002 COVID-19 VACCINE SAFETY IN PATIENTS WITH RHEUMATIC AND MUSCULOSKELETAL DISEASE (2021) (19)
- Differences and similarities in rheumatology specialty training programmes across European countries (2015) (19)
- Rheumatology training experience across Europe: analysis of core competences (2016) (19)
- Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumour necrosis factor inhibitors: results through one year of a phase IIIb, randomised, controlled study (COSMOS) (2021) (19)
- Domains Selection for Patient-Reported Outcomes: Current Activities and Options for Future Methods (2011) (19)
- Application of the European Society of Cardiology, Adult Treatment Panel III and American College of Cardiology/American Heart Association guidelines for cardiovascular risk management in a French cohort of rheumatoid arthritis. (2015) (19)
- Prevention, screening, assessing and managing of non-adherent behaviour in people with rheumatic and musculoskeletal diseases: systematic reviews informing the 2020 EULAR points to consider. (2020) (19)
- Continuation of treatment with infliximab in ankylosing spondylitis: 2-yr open follow-up. (2006) (19)
- Current status of use of big data and artificial intelligence in RMDs: a systematic literature review informing EULAR recommendations (2019) (19)
- Switching between tumour necrosis factor blockers in spondyloarthritis: a retrospective monocentre study of 222 patients. (2011) (18)
- Is a positive family history of spondyloarthritis relevant for diagnosing axial spondyloarthritis once HLA-B27 status is known? (2019) (18)
- Fatigue in Egyptian patients with rheumatic diseases: a qualitative study (2015) (18)
- Toward the Development of a Core Set of Outcome Domains to Assess Shared Decision-making Interventions in Rheumatology: Results from an OMERACT Delphi Survey and Consensus Meeting (2017) (18)
- Big Data and Artificial Intelligence:Will they change our practice? (2020) (17)
- Fatigue in early axial spondyloarthritis. Results from the French DESIR cohort. (2016) (17)
- Cross-cultural validation of the ICOAP and physical function short forms of the HOOS and KOOS in a multi-country study of patients with hip and knee osteoarthritis. (2016) (17)
- EULAR ‘points to consider’ for the conduction of workforce requirement studies in rheumatology (2018) (17)
- Gender differences in patient journey to diagnosis and disease outcomes: results from the European Map of Axial Spondyloarthritis (EMAS) (2021) (17)
- The EULAR Outcome Measures Library: development and an example from a systematic review for systemic lupus erythematous instruments. (2015) (17)
- ASAS recommendations for variables to be collected in clinical trials/epidemiological studies of spondyloarthritis (2012) (16)
- Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 study. (2020) (16)
- The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative Review (2021) (16)
- Effects of etanercept on serum biochemical markers of cartilage metabolism in patients with spondyloarthropathy. (2008) (16)
- Cross-sectional study of self-care safety skills in 677 patients on biodrugs for inflammatory joint disease. (2014) (15)
- The patient global assessment in RA precludes the majority of patients otherwise in remission to reach this status in clinical practice. Should we continue to ignore this? (2020) (15)
- Treatment of psoriatic arthritis: management recommendations. (2015) (15)
- Autonomous online health assessment questionnaire registry in daily clinical practice. (2013) (15)
- Translating patient reported outcome measures: methodological issues explored using cognitive interviewing with three rheumatoid arthritis measures in six European languages. (2016) (15)
- Repeated Anticitrullinated Protein Antibody and Rheumatoid Factor Assessment Is Not Necessary in Early Arthritis: Results from the ESPOIR Cohort (2014) (15)
- SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study (2021) (15)
- Gender equity in clinical practice, research and training: Where do we stand in rheumatology? (2019) (15)
- Minimal Disease Activity among Active Psoriatic Arthritis Patients Treated with Secukinumab: 2-year Results from the FUTURE 2 Study (2018) (15)
- Frequency and tolerance of antituberculosis treatment according to national guidelines for prevention of risk of tuberculosis due to tumor necrosis factor blocker treatment. (2010) (15)
- Remission and low disease activity in psoriatic arthritis publications: a systematic literature review with meta-analysis. (2020) (14)
- Towards standardized patient reported physical function outcome reporting: linking ten commonly used questionnaires to a common metric (2018) (14)
- The learning curve of nurses for the assessment of swollen and tender joints in rheumatoid arthritis. (2014) (14)
- Development and application of a questionnaire to assess patient beliefs in rheumatoid arthritis and axial spondyloarthritis (2018) (14)
- Actualisation des Recommandations de la Société française de rhumatologie pour la prise en charge de la polyarthrite rhumatoïde (2019) (14)
- Evaluation of the performances of ‘typical’ imaging abnormalities of axial spondyloarthritis: results of the cross-sectional ILOS-DESIR study (2019) (14)
- Phrasing of the patient global assessment in the rheumatoid arthritis ACR/EULAR remission criteria: an analysis of 967 patients from two databases of early and established rheumatoid arthritis patients (2018) (14)
- Fatigue in spondyloarthritis: a marker of disease activity. A cross-sectional study of 266 patients. (2013) (14)
- Workforce requirements in rheumatology: a systematic literature review informing the development of a workforce prediction risk of bias tool and the EULAR points to consider (2018) (13)
- Development and psychometric validation of a patient-reported outcome measure to assess fears in rheumatoid arthritis and axial spondyloarthritis: the Fear Assessment in Inflammatory Rheumatic diseases (FAIR) questionnaire (2017) (13)
- SAT0072 Performance of Patient Reported Outcomes in the Assessment of Rheumatoid Arthritis Disease Activity: The Experience of the Espoir Cohort (2015) (13)
- Improving the peer review skills of young rheumatologists and researchers in rheumatology: the EMEUNET Peer Review Mentoring Program (2018) (13)
- Brief Report: Nonsteroidal Antiinflammatory Drug–Sparing Effect of Tumor Necrosis Factor Inhibitors in Early Axial Spondyloarthritis: Results From the DESIR Cohort (2015) (13)
- The relationship of patient-reported joints with active synovitis detected by power Doppler ultrasonography in rheumatoid arthritis. (2013) (12)
- Patient-reported Flares in Ankylosing Spondylitis: A Cross-sectional Analysis of 234 Patients (2017) (12)
- Improving agreement in assessment of synovitis in rheumatoid arthritis. (2013) (12)
- Patient-Reported Outcomes in Rheumatoid Arthritis: Why are They Important and How Should They Be Assessed? (2010) (12)
- Assessing structural changes in axial spondyloarthritis using a low-dose biplanar imaging system. (2014) (12)
- Commentary: Patients as Partners: Building on the Experience of Outcome Measures in Rheumatology (2016) (12)
- OP0053 A Randomized Controlled TRIAL of Improving Patient Self-Assessment of Synovitis in Rheumatoid Arthritis with Education by Ultrasonography: the Raeus Study (2014) (12)
- Factors associated with knowledge and safety skills of arthritis patients receiving biologics: A survey of 677 patients. (2017) (11)
- Maladie de Whipple révélée par les traitements anti-TNFα (2013) (11)
- Wearable Activity Trackers in the Management of Rheumatic Diseases: Where Are We in 2020? (2020) (11)
- Mentoring of young professionals in the field of rheumatology in Europe: results from an EMerging EUlar NETwork (EMEUNET) survey. (2014) (11)
- Comparing the Patient‐Reported Physical Function Outcome Measures in a Real‐Life International Cohort of Patients With Psoriatic Arthritis (2020) (11)
- Validating Rheumatoid Arthritis Remission Using the Patients’ Perspective: Results from a Special Interest Group at OMERACT 2016 (2017) (11)
- Who are the young professionals working in the field of rheumatology in Europe and what are their needs? An EMEUNET (EMerging EUlar NETwork) survey (2012) (11)
- Is the current ASAS expert definition of a positive family history useful in identifying axial spondyloarthritis? Results from the SPACE and DESIR cohorts (2017) (11)
- Usefulness of routine electrocardiography for heart disease screening in patients with spondyloarthropathy or rheumatoid arthritis. (2010) (11)
- Sustainability of TNF-blocker tapering in rheumatoid arthritis over 3 years: long-term follow-up of the STRASS (Spacing of TNF-blocker injections in Rheumatoid ArthritiS Study) randomised controlled trial (2017) (11)
- Effect of Secukinumab on the Different GRAPPA-OMERACT Core Domains in Psoriatic Arthritis: A Pooled Analysis of 2049 Patients (2019) (10)
- Development and initial validation of a questionnaire to assess facilitators and barriers to physical activity for patients with rheumatoid arthritis, axial spondyloarthritis and/or psoriatic arthritis (2020) (10)
- Use of nonsteroidal anti-inflammatory drugs in early axial spondyloarthritis in daily practice: Data from the DESIR cohort. (2017) (10)
- Effectiveness of IL-12/23 inhibition (ustekinumab) versus tumour necrosis factor inhibition in psoriatic arthritis: observational PsABio study results (2021) (10)
- Improvement in patient-reported outcomes after rituximab in rheumatoid arthritis patients: An open-label assessment of 175 patients. (2015) (10)
- Mucopolysaccharidoses seen in adults in rheumatology. (2017) (10)
- Heel pain in spondyloarthritis: results of a cross-sectional study of 275 patients. (2012) (10)
- Effect of filgotinib on health-related quality of life in active psoriatic arthritis: a randomized phase 2 trial (EQUATOR) (2019) (10)
- Evaluation of the impact of a nurse-led program of patient self-assessment and self-management in axial spondyloarthritis: results of a prospective, multicentre, randomized, controlled trial (COMEDSPA). (2020) (10)
- Development of a Flare Instrument for Use in Psoriatic Disease: A Report from the 2015 GRAPPA Annual Meeting (2016) (10)
- Patient-perceived flares in rheumatoid arthritis: A sub-analysis of the STRASS treatment tapering strategy trial. (2017) (10)
- Patient perspective in outcome measures developed by OMERACT (2013) (10)
- COVID-19 in Pregnant Women With Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance (2021) (10)
- Effects of Sarilumab on Rheumatoid Arthritis as Reported by Patients Using the Rheumatoid Arthritis Impact of Disease Scale (2019) (9)
- OP0053 SECUKINUMAB IMPROVES CLINICAL AND IMAGING OUTCOMES IN PATIENTS WITH PSORIATIC ARTHRITIS AND AXIAL MANIFESTATIONS WITH INADEQUATE RESPONSE TO NSAIDS: WEEK 52 RESULTS FROM THE MAXIMISE TRIAL (2020) (9)
- Remission is related to CRP and smoking in early axial spondyloarthritis. The DESIR cohort. (2017) (9)
- Place et forme de l'information et de l'éducation dans la prise en chargede personnes souffrant de polyarthrite rhumatoïde établissement de recommandations pour la pratique clinique à partir de données de la littérature et d'opinions d'experts (rencontres d'experts en rhumatologie) (2004) (9)
- Pain assessment in rheumatology - How can we do better? A literature review. (2016) (9)
- Response to: ‘Correspondence on ‘EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update’ by Fallon et al (2020) (8)
- The Portuguese Rheumatoid Arthritis Impact of Disease (RAID) score and its measurement equivalence in three countries: validation study using Rasch Models (2018) (8)
- Diagnostic and Classification Criteria (1993) (8)
- EULAR/eumusc.net standards of care for rheumatoid arthritis: cross-sectional analyses of importance, level of implementation and care gaps experienced by patients and rheumatologists across 35 European countries (2020) (8)
- Young people’s perspectives on patient-reported outcome measures in inflammatory arthritis: results of a multicentre European qualitative study from a EULAR task force (2021) (8)
- Screening for and management of comorbidities after a nurse-led program: results of a 3-year longitudinal study in 769 established rheumatoid arthritis patients (2019) (8)
- Evaluation of the performance of extreme patient-reported outcomes as surrogate markers for fibromyalgia in axial spondyloarthritis (2018) (8)
- Secukinumab and Sustained Reduction in Fatigue in Patients With Ankylosing Spondylitis: Long‐Term Results of Two Phase III Randomized Controlled Trials (2020) (8)
- Essential knowledge for patients with rheumatoid arthritis or spondyloarthritis Results of a multicentric survey in France among health professionals and patients. (2019) (8)
- Guselkumab demonstrated an independent treatment effect in reducing fatigue after adjustment for clinical response—results from two phase 3 clinical trials of 1120 patients with active psoriatic arthritis (2021) (8)
- The impact of patient global assessment in the definition of remission as a predictor of long-term radiographic damage in patients with rheumatoid arthritis: protocol for an individual patient data meta-analysis. (2018) (8)
- 2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis. (2022) (8)
- Patient Global Assessment of Disease Activity and Radiographic Progression in Early Arthritis: Three‐Year Results From the ESPOIR Cohort (2020) (8)
- Assessment of the adherence to disease-modifying drugs in patients with chronic inflammatory rheumatic diseases: Results of a survey of 1594 patients. (2019) (8)
- Evaluation of the impact of a nurse-led program of systematic screening of comorbidities in patients with axial spondyloarthritis: The results of the COMEDSPA prospective, controlled, one year randomized trial. (2020) (8)
- Place des « proches » dans les programmes d’éducation thérapeutique des patients en rhumatologie : état des lieux et perspectives (2013) (7)
- Comment je fais un bilan échographique des mains et des pieds dans la polyarthrite rhumatoïde (2010) (7)
- Flare in axial spondyloarthritis: investigation of meaningful changes in symptomatic outcome measures. (2017) (7)
- New concepts in the diagnosis and treatment of recent-onset polyarthritis. (2005) (7)
- [Whipple disease revealed by anti-TNFα therapy]. (2013) (7)
- FRI0082 In Addition to Individual Demographic and Clinical Measures, Levels of Fatigue Are Dependent on Country of Residence. An Analysis among 3920 Patients from 17 Countries (The Comora Study) (2014) (7)
- Harmonizing Pain Outcome Measures: Results of the Pre-OMERACT Meeting on Partnerships for Consensus on Patient-important Pain Outcome Domains Between the Cochrane Musculoskeletal Group and OMERACT (2015) (7)
- Determinants of sleep impairment in psoriatic arthritis: an observational study with 396 patients from 14 countries. (2020) (7)
- Gender equity in academic rheumatology: is there a gender gap at European rheumatology conferences? (2022) (7)
- Psychometric properties of sleep and coping numeric rating scales in rheumatoid arthritis: a subanalysis of an etanercept trial. (2017) (6)
- Data to be collected for an optimal management of axial spondyloarthritis in daily practice: Proposal from evidence-based and consensual approaches. (2020) (6)
- Efficacy of rituximab in patients with rheumatoid arthritis refractory or with contra-indication to anti-tumor necrosis factor-alpha drugs in daily practice: an open label observational study. (2007) (6)
- Machine learning approaches to improve disease management of patients with rheumatoid arthritis: review and future directions (2021) (6)
- Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL) (2022) (6)
- HLA DRB1*01 and DRB1*04 phenotyping does not predict the need for joint surgery in rheumatoid arthritis. A retrospective quantitative evaluation of 300 French patients. (2004) (6)
- Validity and reliability of the EULAR instrument RAID.7 as a tool to assess individual domains of impact of disease in rheumatoid arthritis: a cross-sectional study of 671 patients (2021) (6)
- Evidence for Psoriatic Arthritis Impact of Disease (PsAID12) as Core Instrument to Measure Health-Related Quality of Life in Psoriatic Arthritis: A Systematic Review of Psychometric Properties (2019) (6)
- SAT0115 COGNITIVE IMPAIRMENT WAS FREQUENT IN PATIENTS WITH RHEUMATOID ARTHRITIS STARTING A BIOLOGIC, WITH SIMILAR RATES OF INHIBITION OR OVERSTIMULATION: AN ANALYSIS OF 84 PATIENTS FROM THE SARIPRO STUDY (2020) (6)
- Person-focused care for young people with rheumatic and musculoskeletal diseases: young rheumatologists' and EULAR Young PARE perspectives (2017) (6)
- Influence of perceived barriers and facilitators for physical activity on physical activity levels in patients with rheumatoid arthritis or spondyloarthritis: a cross-sectional study of 150 patients (2021) (6)
- Persistence and effectiveness of the IL-12/23 pathway inhibitor ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: 1-year results from the real-world PsABio Study (2022) (6)
- Gender equity in academic rheumatology, current status and potential for improvement: a cross-sectional study to inform an EULAR task force (2022) (6)
- Self-reported prevalence of psoriasis and evaluation of the impact on the natural history of hip osteoarthritis: results of a 10 years follow-up study of 507 patients (ECHODIAH study). (2009) (6)
- Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE) (2022) (5)
- Ef fi cacy of conventional synthetic disease-modifying antirheumatic drugs , glucocorticoids and tofacitinib : a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis (2014) (5)
- Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists (2010) (5)
- OP0244 Family matters: value of family history of spondyloarthritis in the diagnostic work-up of patients with chronic back pain: results from the space and desir cohorts (2017) (5)
- FRI0222 Translation and Cross-Cultural Adaptation of the ASAS Health Index and the Environmental Item Set into 15 Languages (2014) (5)
- Prevalence and clinical characteristics of psoriasis in spondyloarthritis: a descriptive analysis of 275 patients. (2016) (5)
- Measurable definitions of ankylosing spondylitis management recommendations are needed for use in observational studies. (2016) (5)
- Actualisation 2018 des recommandations de la Société française de rhumatologie (SFR) pour la prise en charge en pratique courante des malades atteints de spondyloarthrite (2018) (5)
- Patient-reported outcomes in Asia: evaluation of the properties of the Rheumatoid Arthritis Impact of Disease (RAID) score in multiethnic Asian patients with rheumatoid arthritis (2017) (5)
- Development of a comorbidity self-questionnaire for patients with inflammatory joint disease. (2017) (5)
- Influence of the experience of the reader on reliability of joint space width measurement. A cross-sectional multiple reading study in hip osteoarthritis. (2011) (5)
- FRI0362 COMPARATIVE EFFECTIVENESS OF USTEKINUMAB (UST) AND TNF INHIBITORS (TNFI) IN PATIENTS WITH PSORIATIC ARTHRITIS (PSA) IN THE REAL-WORLD, MULTINATIONAL PSABIO STUDY: 12-MONTH FOLLOW-UP (2020) (5)
- Lack of efficacy of tocilizumab in severe axial refractory spondyloarthritis: a report of 5 patients. (2012) (5)
- EULAR COVID-19 registry: lessons learnt and future considerations (2021) (5)
- Pregnancy appears difficult to obtain and TNF-alpha blockers cannot always be discontinued in women with rheumatic diseases. (2009) (5)
- The controversy of using PGA to define remission in RA (2018) (5)
- AB0778 ASSOCIATION BETWEEN PATIENT-REPORTED OUTCOMES AND DISEASE ACTIVITY IN BIMEKIZUMAB-TREATED PATIENTS WITH PSORIATIC ARTHRITIS (2020) (4)
- Cross-cultural adaptation and validation of the French version of the Rheumatoid and Arthritis Outcome Score (RAOS). (2010) (4)
- OP0111 Elaboration and Preliminary Validation of the Psoriatic Arthritis Impact of Disease (PsAID) Questionnaire. A 13-Country Eular Initiative with Involvement of Patient Research Partners from Each Country (2013) (4)
- Sanoïa®, plateforme e-santé interactive d’auto-évaluation dans la polyarthrite rhumatoïde. Essai comparatif randomisé de 12 mois sur 320 patients (2019) (4)
- AB0794 Intra-Articular Injections in Thumb Osteoarthritis. A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2014) (4)
- Is self-assessment by patients of disease activity acceptable over the long term in rheumatoid arthritis? A 3-year follow-up of 771 patients. (2019) (4)
- FRI0622-HPR What Competencies for Rheumatology Nurses? Results of a Multicentric Survey Among Health Professionals and Nurses in France (2015) (4)
- Évaluer les programmes d’éducation thérapeutique (2013) (4)
- SP0035 Eular Recommendation Update on the Management of Psoriatic Arthritis (2015) (4)
- THU0580 EULAR TASK FORCE ON GENDER EQUITY IN ACADEMIC RHEUMATOLOGY: PRELIMINARY SURVEY FINDINGS (2020) (4)
- OP0006 ASSOCIATIONS OF BASELINE USE OF BIOLOGIC OR TARGETED SYNTHETIC DMARDS WITH COVID-19 SEVERITY IN RHEUMATOID ARTHRITIS: RESULTS FROM THE COVID-19 GLOBAL RHEUMATOLOGY ALLIANCE (2021) (4)
- Development and Validation of a Questionnaire Assessing the fears and Beliefs of Patients Suffering from Chronic Rheumatic Diseases. (2015) (4)
- Safety and Efficacy of Bimekizumab in Patients With Active Psoriatic Arthritis: Three‐Year Results From a Phase IIb Randomized Controlled Trial and Its Open‐Label Extension Study (2022) (4)
- To apply the recent EULAR recommendations, more knowledge on adherence patterns to medication and to physical activity is needed. (2021) (4)
- Upadacitinib as monotherapy and in combination with non-biologic disease-modifying antirheumatic drugs for psoriatic arthritis (2021) (4)
- Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study (2022) (4)
- [MR Imaging of the spine and sacroiliac joints in ankylosing spondylitis]. (2010) (4)
- Prevalence and consequences of psoriasis in recent axial spondyloarthritis: an analysis of the DESIR cohort over 6 years (2022) (4)
- Outcome measures used in psoriatic arthritis registries and cohorts: A systematic literature review of 27 registries or 16,183 patients. (2021) (4)
- Frequency of tumour necrosis factor alpha receptor superfamily 1A multiple sclerosis-associated variants in patients with rheumatoid arthritis with anti-tumour necrosis factor therapy-related demyelinating complications (2018) (4)
- Iconography : Mortality in rheumatoid arthritis over the last fifty years: Systematic review and meta-analysis (2012) (4)
- SAT0627-HPR Educational Needs of French Rheumatology Nurses Are Not Limited To Inflammatory Arthritis Management. Results of The Multicentric “Caire” Survey (2016) (4)
- The Most Frequent Fears and Beliefs of 226 Patients with Rheumatoid Arthritis or Spondyloarthritis, Using a Novel Questionnaire. (2015) (4)
- The effects of cultural background on patient-perceived impact of psoriatic arthritis - a qualitative study conducted in Brazil and France (2018) (4)
- Development and validation of a questionnaire categorizing behavioral strategies in patients with chronic low back pain. (2017) (3)
- AB0928 Ustekinumab and tnf inhibitors in psoriatic arthritis: first follow-up data from a routine care study in 8 european countries (PSABIO) (2018) (3)
- Secukinumab Provides Sustained Minimal Disease Activity (MDA) and Remission Related to Disease Activity Index for Psoriatic Arthritis (DAPSA): 2-Year Results from a Phase 3 Study (2017) (3)
- THU0412 Pharmacological Treatment of Psoriatic Arthritis (PSA): Systematic Literature Review for the Update of the Eular Recommendations for the Management of PSA (2015) (3)
- EULAR recommendations for the inclusion of patient representatives in scientific projects: A EULAR initiative (2011) (3)
- Is the widely-used score in axial spondyloarthritis, Bath Ankylosing Spondylitis Disease Activity Index, influenced by patients' optimism? A cross-sectional study of 206 patients. (2017) (3)
- LB0001 BIMEKIZUMAB IN BDMARD-NAIVE PATIENTS WITH PSORIATIC ARTHRITIS: 24-WEEK EFFICACY & SAFETY FROM BE OPTIMAL, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED, ACTIVE REFERENCE STUDY (2022) (3)
- Professional practice assessment in ambulatory private rheumatology: a pilot evaluation of the medical file content for rheumatoid arthritis. (2008) (3)
- OP0007 HIGH BODY MASS INDEX (BMI) IN PSORIATIC ARTHRITIS (PSA) IS ASSOCIATED WITH HIGHER DISEASE ACTIVITY IN JOINTS AND SKIN, IMPAIRED QUALITY OF LIFE AND MORE DISABILITY: RESULTS FROM THE PSABIO STUDY (2019) (3)
- Effect of bimekizumab on symptoms and impact of disease in patients with psoriatic arthritis over 3 years: results from BE ACTIVE (2022) (3)
- OP0162 Degenerative Changes of the Spine on MRI in Patients with Inflammatory Back Pain from the DESIR Cohort (2014) (3)
- Improvements in Fatigue in 1536 Patients with Rheumatoid Arthritis and Correlation with Other Treatment Outcomes: A Post Hoc Analysis of Three Randomized Controlled Trials of Abatacept (2017) (3)
- Criteria for inclusion in programs of functional restoration for chronic low back pain: pragmatic study. (2020) (3)
- Wearable activity trackers and artificial intelligence in the management of rheumatic diseases (2021) (3)
- SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry (2022) (3)
- Monitoring of Disease and Treatment of Patients With Rheumatic Disease (2018) (3)
- Impact of repeated measures of joint space width on the sample size calculation: An application to hip osteoarthritis. (2015) (3)
- Quelles nouveautés dans le diagnostic et le traitement d'une polyarthrite rhumatoïde récente (2005) (3)
- IRM du rachis et des articulations sacro-iliaques dans la spondylarthrite ankylosante (2010) (3)
- Psoriatic Arthritis Impact of Disease Questionnaire (2020) (3)
- Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry (2022) (3)
- THU0151 Effects of Tnfα-Blockers Tapering on Occurrence of Patient-Perceived Flares in Rheumatoid Arthritis: A Subanalysis of Strass (2014) (3)
- FRI0436 ACHIEVING THE TREATMENT TARGETS OF REMISSION OR LOW DISEASE ACTIVITY (LDA) IN PSORIATIC ARTHRITIS (PSA) IS ASSOCIATED WITH SIGNIFICANTLY IMPROVED QUALITY OF LIFE, FUNCTION AND PAIN (2019) (3)
- Attainment of the Patient-acceptable Symptom State in 548 patients with rheumatoid arthritis: influence of demographic factors. (2020) (3)
- Erratum to: Rheumatology training experience across Europe: analysis of core competences (2016) (3)
- FRI0463 ENTHESITIS, DACTYLITIS, AND AXIAL DISEASE IN PSORIATIC ARTHRITIS (PSA): IMPACT ON PATIENT QUALITY OF LIFE AND WORK PRODUCTIVITY (2019) (3)
- Evaluation of the Implementation of Guidelines on the Treatment of Osteoporosis in Patients with Rheumatoid Arthritis (2019) (3)
- POS1022 BIMEKIZUMAB SAFETY AND EFFICACY IN PATIENTS WITH PSORIATIC ARTHRITIS: 3-YEAR RESULTS FROM A PHASE 2b OPEN-LABEL EXTENSION STUDY (2021) (3)
- Concomitant therapies as an outcome measure. Part 1: Drugs. (2005) (3)
- THU0594 Towards Development of A Minimum Core Dataset and Standards of Data Collection for Observational Rheumatoid Arthritis Research – A EULAR Initiative (2016) (2)
- Women With Psoriatic Arthritis Experience Higher Disease Burden Than Men: Findings From a Real-World Survey in the United States and Europe (2022) (2)
- P184 Secukinumab provides sustained improvements in clinical and imaging outcomes in patients with psoriatic arthritis and axial manifestations: results from the MAXIMISE trial (2021) (2)
- The Patient Experienced Symptom State (PESS): a patient-reported global outcome measure that may better reflect disease remission status. (2020) (2)
- Discriminant Capacity of Clinical Efficacy and Nonsteroidal Antiinflammatory Drug-sparing Endpoints, Alone or in Combination, in Axial Spondyloarthritis (2015) (2)
- Patient-Perceived Impact of Psoriatic Arthritis Is Due to Pain and Fatigue, but Also to Psychological Aspects - the Psa Impact of Disease Study (2011) (2)
- THU0448 Safety competences knowledge and behavioural skills of patients treated by biologics in rheumatology (2013) (2)
- OP0003 Are patient global and fatigue predictive of structural outcomes, 3 years later, in patients in remission in early arthritis? Results from the french espoir cohort (2013) (2)
- 245 Remission/low disease activity is an achievable treatment target in psoriatic arthritis (PsA): results from a routine care European cohort of PsA patients treated with ustekinumab or TNF inhibitors (2019) (2)
- Correspondence on ‘Re-examining remission definitions in rheumatoid arthritis: considering the 28-joint Disease Activity Score, C reactive protein level and patient global assessment’ by Felson et al (2022) (2)
- FRI0071 Does psychological status drive patient global assessment for rheumatoid arthritis patients who do not have any clinical signs of inflammation? an exploratory analysis of near-remission using the rheumatoid arthritis impact of disease (RAID) score. (2013) (2)
- THU0167 ASSOCIATIONS BETWEEN RHEUMATOID ARTHRITIS DISEASE ACTIVITY AND PATIENT-REPORTED OUTCOMES IN SARILUMAB CLINICAL TRIALS (2020) (2)
- THU0237 Inflammatory lesions of the sacroiliac joints, but not of the spine, are of high utility for axspa recognition: results of the ilos-desir study (2018) (2)
- OP0303 Systematic screening of comorbidities improves vaccination rates, skin cancer screening and vitamin d supplementation in patients with axial spondyloarthritis: results of the comedspa prospective, controlled, one year randomised trial (2018) (2)
- FRI0203 Is Patient-Physician Discordance in Global Assessment in Early Spondyloarthritis Varying Over Time: The Desir Cohort (2015) (2)
- Correspondence on “Re‐examining remission definitions in rheumatoid arthritis: considering the 28‐Joint Disease Activity Score, C‐reactive protein level and patient global assessment” by Felson et al (2022) (2)
- OP0285 The Eular Task Force for Standardising Minimum Data Collection in Rheumatoid Arthritis Observational Research: Results of A Hierarchical Literature Review (2016) (2)
- 176 Secukinumab provides sustained reduction in fatigue in patients with ankylosing spondylitis through three years: long-term results of two randomised double-blind placebo-controlled phase III studies (2018) (2)
- Acute renal failure after intravenous immunoglobulin therapy. (2010) (2)
- OP0164-HPR Impact of a nurse-led program of patient self-assessment and self-management axial spondyloarthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDSPA) (2018) (2)
- Patients as Collaborative Partners in Clinical Research to Inform HTA (2017) (2)
- AB0560 EFFECT OF DEUCRAVACITINIB ON THE PSORIATIC ARTHRITIS IMPACT OF DISEASE (PsAID) QUESTIONNAIRES 12 AND 9: ANALYSIS OF A PHASE 2 STUDY OF ACTIVE PSORIATIC ARTHRITIS (2021) (2)
- Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial Spondyloarthritis. (2021) (2)
- THU0620 Gender, Disease Activity, Anxiety and Depression Levels Are Related To The Levels of Fears of Patients with Rheumatoid Arthritis or Axial Spondyloarthritis: A Cross-Sectional Study of 672 Patients (2016) (2)
- Les répercussions de la lombalgie chronique sont en partie liées à la perte du rôle social : une étude qualitative (2015) (2)
- 077. PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS ACHIEVING MINIMAL DISEASE ACTIVITY WITH SECUKINUMAB TREATMENT DEMONSTRATE SUSTAINED IMPROVEMENT OF FUNCTION AND QUALITY OF LIFE (2017) (2)
- Évaluer la douleur en rhumatologie – comment faire mieux ? Revue de la littérature (2016) (2)
- IRM et spondylarthropathie (2009) (2)
- Guselkumab provides sustained domain-specific and comprehensive efficacy using composite indices in patients with active psoriatic arthritis (2022) (2)
- SAT0403 Patients with Chronic Low Back Pain Develop Over Time Positive Coping Strategies Include Striving for Normality, Dealing with Pain, Having High Levels of Physical Activity and Maintaining Social Connections: A Qualitative Study. (2013) (2)
- Measuring treatment effect on psoriatic arthritis-related domains: insights from the SPIRIT-H2H study at weeks 24 and 52 (2021) (2)
- THU0442 Reduction in Fatigue in Patients with Active Psoriatic Arthritis Are Sustained over 2 Years: Long-Term Results of Two Phase 3 Studies with Secukinumab (2016) (2)
- Efficacy of a nurse-led patient education intervention in promoting safety skills of patients with inflammatory arthritis treated with biologics: a multicentre randomised clinical trial (2022) (2)
- OP0040 Patients from Wealthier Countries Perform Better on Clinical Disease Activity Measures, but Show Worse Person Reported Outcomes (2014) (2)
- [US evaluation of the hands and feet in rheumatoid arthritis]. (2010) (2)
- Spinal-pelvic orientation: potential effect on the diagnosis of spondyloarthritis. (2019) (2)
- SAT0398 PERSISTENCE OF USTEKINUMAB (UST) OR TNF INHIBITOR (TNFI) TREATMENT IN PSORIATIC ARTHRITIS (PsA): INSIGHTS FROM THE LARGE, PROSPECTIVE, MULTINATIONAL, REAL-WORLD PsABio COHORT (2020) (2)
- Obstetric Outcomes in Women with Rheumatic Disease and COVID-19 in the Context of Vaccination Status. (2022) (2)
- OP0232 FEMALE VERSUS MALE BURDEN OF PSORIATIC ARTHRITIS IS HIGHER AND TREATMENT PERSISTENCE SHORTER AFTER USTEKINUMAB OR TUMOUR NECROSIS FACTOR INHIBITOR TREATMENT: 1-YEAR DATA FROM THE PSABIO STUDY (2021) (2)
- Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’ by Arnaud and Devilliers (2021) (2)
- OP0230 EFFICACY AND SAFETY OF GUSELKUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS WHO DEMONSTRATED INADEQUATE RESPONSE TO TUMOR NECROSIS FACTOR INHIBITION: WEEK 24 RESULTS OF A PHASE 3B, RANDOMIZED, CONTROLLED STUDY (2021) (2)
- PMS21 COST-EFFECTIVENESS SIMULATION MODEL OF ABATACEPT VERSUS RITUXIMAB IN RHEUMATOID ARTHRITIS IN FRANCE (2008) (2)
- Patients' safety skills assessment with biologics and JAK inhibitors: update of the BioSecure questionnaire. (2021) (2)
- PMS28 COST OF RHEUMATOID ARTHRITIS MODEL PER LEVEL OF DISEASE ACTIVITY IN FRANCE (2008) (2)
- Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, observational study (2022) (1)
- Predictors of response to secukinumab in patients with psoriatic arthritis and axial manifestations: a post-hoc analysis of the MAXIMISE trial (2022) (1)
- SAT0318 Do patients in remission in psoriatic arthritis, have less fatigue? and does this depend on the definition of remission? an analysis of 304 patients (2018) (1)
- THU0684 Work impact in axial spondyloarthritis: the as-wis questionnaire predicts the risk of work impact: a longitudinal study of 101 patients (2017) (1)
- THU0637 Impact of Psoriatic Arthritis: Linking The Domains of Health Which Are Important for Patients with Psoriatic Arthritis To The International Classification of Functioning, Disability and Health (2016) (1)
- FRI0472 Extra-rheumatological features are frequently associated with peripheral rheumatological features in axial spondyloarthritis and influence the choice of the anti-tnf in daily practice. an analysis of 519 patients (2017) (1)
- Evaluation of the agreement between the ACR 1990 fibromyalgia tender points and an enthesitis score in patients with axial spondyloarthritis. (2022) (1)
- POS0243 WHAT DOES REMISSION IN AXIAL SPONDYLOARTHRITIS MEAN FOR CLINICIANS? AN EXPLORATORY STUDY OF 200 FRENCH RHEUMATOLOGISTS BASED ON A VIGNETTE EXERCISE INCLUDING 36 CASES AND PRIORITY RATINGS (2021) (1)
- THU0381 PATIENT-REPORTED IMPACT OF AXIAL SPONDYLOARTHRITIS ON WORKING LIFE: RESULTS FROM THE EMAS SURVEY (2019) (1)
- THU0745-HPR Use of wearable activity trackers to improve physical activity behaviour in rheumatic conditions – a systematic review (2018) (1)
- POS1212 SARS-CoV-2 VACCINE SAFETY IN ADOLESCENTS WITH INFLAMMATORY RHEUMATIC AND MUSCULOSKELETAL DISEASES AND ADULTS WITH JUVENILE IDIOPATHIC ARTHRITIS (2022) (1)
- Patient experienced symptom state in rheumatoid arthritis: sensitivity to change in disease activity and impact. (2022) (1)
- SAT0463 Secukinumab provides sustained reduction in fatigue in patients with active psoriatic arthritis through 3 years: long-term data from the future 1 and future 2 studies (2017) (1)
- SAT0629 THERE ARE 4 MAIN QUESTIONNAIRES TO ASSESS ADHERENCE IN INFLAMMATORY ARTHRITIS BUT NONE OF THEM PERFORM WELL: A SYSTEMATIC LITERATURE REVIEW (2019) (1)
- Reply (2010) (1)
- On publication policy, combination therapy, and the European League Against Rheumatism recommendations for the management of rheumatoid arthritis: comment on the article by Graudal et al. (2011) (1)
- T.5. Th1 versus Th17 Cells in Ankylosing Spondylitis (2009) (1)
- AB1156 Involvement of Patient Research Partners in Clinical Research: Recommendations Developed by Omeract (2015) (1)
- What influences patients' opinion of remission and low disease activity in psoriatic arthritis? Principal component analysis of an international study of 424 patients. (2021) (1)
- Disease activity of patients with rheumatoid arthritis (RA) seen in standard rheumatology care in 20 countries in the quest RA study (2007) (1)
- Self-reported competencies and educational needs of rheumatology nurses: results of a national survey. (2019) (1)
- POS1024 GUSELKUMAB PROVIDES SUSTAINED DOMAIN-SPECIFIC AND COMPREHENSIVE EFFICACY AS ASSESSED USING COMPOSITE ENDPOINTS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS (2021) (1)
- FRI0367 Fatigue is an Internationally Valid Concept: The Bristol RA Fatigue Multi-Dimensional Questionnaire (BRAF-MDQ) in 6 EU Countries (2015) (1)
- Chapter 11 – Diagnostic and Classification Criteria (2006) (1)
- The updated GRAPPA and EULAR recommendations for the management of psoriatic arthritis: similarities and differences. (2022) (1)
- Development of a Prediction Model for COVID‐19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance Registry (2022) (1)
- Similar alteration for mental and physical aspects in health-related quality of life over 5 to 8 years in 1347 patients with early arthritis and early inflammatory back pain (2019) (1)
- OP0286 CHARACTERISTICS ASSOCIATED WITH SEVERE COVID-19 OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): RESULTS FROM THE COVID-19 GLOBAL RHEUMATOLOGY ALLIANCE (COVID-19 GRA) (2021) (1)
- FRI0140 Developing Quality Criteria from the Assessments in Ankylosing Spondylitis Society (ASAS) and European League against Rheumatism (EULAR) Ankylosing Spondylitis Management Recommendations: towards Quantitative Definitions of “Non-Compliance” (2014) (1)
- SAT0473 Defining cut-off values for disease activity states and improvement scores for patient-reported outcomes: the example of the rheumatoid arthritis impact of disease (RAID) (2013) (1)
- Functional restoration programs for chronic low back pain patients are not just a fitness class – change in muscle mass assessed through DXA in 95 patients: a monocentric longitudinal study (2014) (1)
- PROMs for Spondyloarthritis (2016) (1)
- [Spondyloarthropathy: MR imaging features]. (2010) (1)
- AB1162-HPR Relationship between Optimism and Quality of Life in Patients with Chronic Rheumatic Diseases: A Systematic Literature Review (2014) (1)
- Defining and managing flares in axial spondyloarthritis (2022) (1)
- Needs, Experiences, and Views of People With Rheumatic and Musculoskeletal Diseases on Self-Management Mobile Health Apps: Mixed Methods Study (Preprint) (2019) (1)
- Effectiveness of a Short Functional Restoration Program for Patients with Chronic Low Back Pain: a cohort study of 193 Patients. (2020) (1)
- SAT0578 Patients with Rheumatoid Arthritis, Spondyloarthritis and Psoriatic Arthritis Treated with BIOLOGICS Use Similar Coping Strategies: A Study of 671 Patients (2014) (1)
- 432 INTER- AND INTRA-OBSERVER REPRODUCIBILITY OF THE RADIOGRAPHIC KELLGREN-LAWRENCE SCORING SYSTEM IN HAND OSTEOARTHRITIS (HOA) (2009) (1)
- Psychometric properties and cross-language equivalence of the revised Bristol Rheumatoid Arthritis Fatigue and the Rheumatoid Arthritis Impact of Disease scales in rheumatoid arthritis (2019) (1)
- THU0642 EULAR POINTS TO CONSIDER FOR THE DEVELOPMENT, EVALUATION AND IMPLEMENTATION OF MOBILE HEALTH APPLICATIONS FOR SELF-MANAGEMENT IN PATIENTS WITH RHEUMATIC AND MUSCULOSKELETAL DISEASES (2019) (1)
- Exploring remission concept in axial spondyloarthritis through the perception of rheumatologists using vignettes and priority ratings. (2021) (1)
- OP0268 The Eular Outcome Measure Library, An Evolutional Database of Validated Patient-Reported Outcomes: Use and Dissemination in The First Two Years (2016) (1)
- SAT0635 PATIENT-PERCEIVED RESIDUAL BURDEN OF PSORIATIC ARTHRITIS IN PATIENTS IN REMISSION/LOW DISEASE: AN ANALYSIS OF 444 PATIENTS (2019) (1)
- FRI0602 Eular ‘points to consider’ for the conduction of workforce requirement studies in rheumatology (2018) (1)
- THU0658 Recommendations for the assessment and optimisation of adherence to disease-modifying drugs in chronic inflammatory rheumatic diseases: a process based on literature reviews and consensus (2018) (1)
- THU0375 ASDAS-Based Remission Was Less Frequent than BASDAI-Based Remission, and Both Were Related To CRP and Smoking in Early Axial Spondyloarthritis. The Desir Cohort (2016) (1)
- 411 REQUIREMENT FOR TOTAL ARTICULAR REPLACEMENT AFTER DIACEREIN TREATMENT IN HIP OSTEOARTHRITIS: A 5 YEARS FOLLOW-UP OF THE 3 YEARS PLACEBO-CONTROLLED ECHODIAH TRIAL (2007) (1)
- FRI0667 IS OBESITY A FACTOR OF POOR OUTCOME IN SPONDYLOARTHRITIS? AN ANALYSIS OF 638 PATIENTS (2019) (1)
- How to Define Remission and Low Disease Activity in Psoriatic Arthritis? an Analysis of 419 Patients with a Double Perspective, Based on Composite Scores and Patients' and Physicians' Perspectives (2018) (1)
- Spine abnormalities associated with bone edema on sacroiliac joints MRI in patients with definite non-ax-SpA mechanical chronic back pain. (2022) (1)
- THU0356 The rank of administration and not the molecule has an impact on the anti tnf treatment response in axial spa (2017) (1)
- FRI0240 Rheumatoid arthritis (RA) impact following treatment with sarilumab: patient reported outcomes using the raid scale from two randomized phase III trials (2017) (1)
- Patient-reported outcome measures in psoriatic arthritis (2018) (1)
- FRI0190 Cognitive Interviewing is Crucial in Translating Patient Reported Outcome Measures (PROMS): an International Study in 6 Countries (2014) (1)
- POS0274-HPR BARRIERS TO PHYSICAL ACTIVITY COLLECTED BY THE IFAB QUESTIONNAIRE CORRELATE WITH LEVELS OF PHYSICAL ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS OR SPONDYLOARTHRITIS: A CROSS-SECTIONAL STUDY OF 150 PATIENTS (2021) (1)
- SAT0421 Reduction in Fatigue in Patients with Active Ankylosing Spondylitis: Results of Two Phase 3 Studies of Secukinumab (2016) (1)
- THU0716-HPR MAJOR BARRIERS AND FACILITATORS TO PHYSICAL ACTIVITY IN RHEUMATOID ARTHRITIS ARE RELATED TO PHYSICAL AND PSYCHOLOGICAL HEALTH, SETTING AND SOCIAL ENVIRONMENTAL FACTORS: A SYSTEMATIC LITERATURE REVIEW (2019) (1)
- Primary inefficacy of TNF inhibitors in patients with axial spondyloarthritis: a long-term follow-up of 25 patients (2017) (1)
- FRI0748-HPR Cross-cultural validation of the portuguese “rheumatoid arthritis impact of disease” score: cross-sectional study (2017) (1)
- THU0689 Variability of pain levels is explained by self-reported disease activity in rheumatoid arthritis and axial spondyloarthritis: a 3-months prospective study of 165 patients (2018) (1)
- THU0575 The Most Frequent Fears and Beliefs of 226 Patients with Rheumatoid Arthritis or Spondyloarthritis, Using a Novel Questionnaire (2015) (1)
- THU0621 One Third of Patients with Established Rheumatoid Arthritis (RA) Are Correctly Vaccinated against Influenza and Pneumococcus and This Is Increasing: 3 Year Longitudinal Assessment of 776 Patients (2016) (1)
- Correction to: Development and application of a questionnaire to assess patient beliefs in rheumatoid arthritis and axial spondyloarthritis (2018) (1)
- THU0633 The Revised Bristol RA Fatigue Nrs, Containing New Nrs-Coping Anchors (Braf-NRS V2 Revised): Validity across 6 European Countries (2016) (1)
- SAT0678 DEVELOPMENT AND VALIDATION OF A SELF-ADMINISTRATED QUESTIONNAIRE MEASURING ESSENTIAL KNOWLEDGE FOR PATIENTS WITH SPONDYLOARTHRITIS : THE SPONDYLOARTHRITIS ASSESSMENT KNOWLEDGE QUESTIONNAIRE(SPAKE): (2019) (1)
- Disease Control with Upadacitinib in Patients with Psoriatic Arthritis: A Post Hoc Analysis of the Randomized, Placebo-Controlled SELECT-PsA 1 and 2 Phase 3 Trials (2022) (1)
- POS1035 UPADACITINIB AS MONOTHERAPY AND IN COMBINATION WITH NON-BIOLOGIC DMARDs FOR THE TREATMENT OF PSORIATIC ARTHRITIS: SUBGROUP ANALYSIS FROM TWO PHASE 3 TRIALS (2021) (1)
- POS0930 SECUKINUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS AND AXIAL MANIFESTATIONS: PREDICTORS OF RESPONSE FROM THE DOUBLE-BLIND, RANDOMISED, PHASE 3B MAXIMISE TRIAL (2021) (1)
- SP0062 What is the Influence of the Patient Component in RA Remission Criteria? (2013) (1)
- THU0619 Lifestyle Beliefs of 672 Patients with Rheumatoid Arthritis or Axial Spondyloarthritis (2016) (1)
- OP0011 Rheumatology Training Experience – European Survey Among Rheumatology Trainees & Newly Qualified Specialists (2015) (1)
- SAT0334 Patient-Physician Discordance in Global Assessment in Rheumatoid Arthritis: A Systematic Review of the Literature (2015) (1)
- AB1086 Evaluation of the Properties of the Rheumatoid Arthritis Impact of Disease (RAID) Score in Multiethnic Asian Patients with Rheumatoid Arthritis (2014) (1)
- Development and validation of a questionnaire for the identification of different behavioral strategies in patients with low back pain (2014) (1)
- Les traitements non médicamenteux dans la prise en charge de personnes atteintes de polyarthrite rhumatoïde récente : établissement de recommandations pour la pratique clinique à partir de données de la littérature et d'opinions d'experts (2005) (1)
- Recommandations pour le traitement du rhumatisme psoriasique en 2020 (2020) (1)
- Nouveautés pour le diagnostic de spondylarthropathie (2010) (1)
- L’automédication en rhumatologie (2012) (1)
- Valeur diagnostique et prédictive des anticorps anti-peptides cycliques citrullinés (anti-CCP) dans la polyarthrite rhumatoïde: revue systématique de 68 études (2006) (1)
- Pourquoi les rhumatologues devraient-ils s’intéresser à la sexualité des patients souffrant d’une polyarthrite rhumatoïde ?☆ (2010) (1)
- Tolérance des biothérapies : élaboration et validation d’un questionnaire évaluant les compétences d’auto-gestion et de sécurité du patient : le questionnaire BioSecure. Une initiative de la Société française de rhumatologie, section Éducation thérapeutique (2013) (1)
- La rémission est associée à la CRP et au tabagisme dans la spondyloarthrite axiale débutante. La cohorte DESIR (2017) (1)
- Amélioration des résultats rapportés par les patients atteints de polyarthrite rhumatoïde traités par rituximab : évaluation ouverte de 175 patients (2016) (1)
- L' évaluation structurale dans la prise en charge de personnes souffrant de polyarthrite rhumatoïde établissement de recommandations pour la pratique clinique à partir de données de la littérature et d'opinions d'experts (rencontres d'experts en rhumatologie) (2004) (1)
- Les critères d’évaluation rapportés par le patient en rhumatologie (2015) (1)
- Intérêt de l’électrocardiogramme systématique dans le dépistage de l’atteinte cardiaque au cours des spondylarthropathies et de la polyarthrite rhumatoïde (2010) (1)
- Égalité femmes-hommes dans la pratique clinique, la recherche et la formation : où en est la rhumatologie ? (2020) (1)
- Recommandations pour l’évaluation et l’optimisation de l’adhésion aux traitements de fond médicamenteux des rhumatismes inflammatoires chroniques : un processus basé sur des revues de la littérature et un consensus d’experts (2019) (1)
- Évaluation de l’activité du rhumatisme psoriasique (2020) (1)
- La place de la e-santé et les objets connectés dans le traitement de patients atteints de polyarthrite rhumatoïde (2017) (1)
- Critères de suivi d’activité ou de réponse thérapeutique. Définitions, principes, interprétation (2010) (1)
- Fréquence de prescription et tolérance du traitement antituberculeux effectué selon les recommandations nationales pour prévenir le risque de tuberculose induite par un traitement anti-TNFα (2010) (1)
- FRI0668 Item response theory to standardize patient reported physical function outcomes; linking 10 commonly used questionnaires to a common metric (2018) (0)
- FRI0355 Development of a Patient Version of the Recommendations of the French Society of Rheumatology for Managing Rheumatoid Arthritis (2015) (0)
- The Journal of Rheumatology BiomarkersUpdating the OMERACT Filter: Implications for Imaging and Soluble (0)
- FRI0076 Need for Statins in Rheumatoid Arthritis Patients with High Cardiovascular Risk: Differences According to European and American Recommendations. the Comedra Study (2014) (0)
- FRI0239 The Median Diagnostic Delay is Around 2 Years in Axial Spondyloarthritis: A Cross Sectional Study of 432 French Patients (2015) (0)
- Facteurs de risque de fractures vertébrales: données des 6 ans de l'étude prospective OPUS (2007) (0)
- The Journal of Rheumatology of Functioning , Disability and Health Mapping the Effect of Psoriatic Arthritis Using the International Classification (2016) (0)
- Disparities in healthcare in psoriatic arthritis: an analysis of 439 patients from 13 countries (2022) (0)
- THU0333 Recommendations for Screening of Frequent Comorbidities are Sparse and Incomplete in Chronic Inflammatory Rheumatic Diseases: A Systematic Literature Review for a Eular Project (2015) (0)
- Amélioration durable de la fonction physique, de l’impact de la maladie et de la qualité de vie chez les patients atteints de rhumatisme psoriasique traités par bimékizumab : résultats à 3 ans d’une étude d’extension en ouvert de phase IIb (2021) (0)
- POS1450 PATIENTS’ SAFETY SKILLS ASSESSMENT WITH BIOLOGICS AND JAK INHIBITORS: UPDATE OF THE BIOSECURE QUESTIONNAIRE (2021) (0)
- Suivi prospectif des variations de poids, de composition corporelle et de densité osseuse des patients atteints de spondyloarthropathie traités par anti-TNF alpha (2006) (0)
- THU0315 Patient-perceived involvement in disease management drives patient-physician alignment in satisfaction with disease control in psoriatic arthritis (2018) (0)
- FRI0700 Physical activity decreased significantly but moderately during weeks where patients reported flares: a 3-month study of 170 rheumatoid arthritis (RA) or axial spondyloarthritis (AXSPA) patients wearing an activity tracker (2017) (0)
- EMerging EULAR NETwork (EMEUNET): a remarkable foundation for the future (2021) (0)
- SAT0267 Is the Widely-Used Score in Axial Spondyloarthritis, Basdai (Bath Ankylosing Spondylitis Diseases Activity Index), Influenced by Patients' Optimism? a Cross-Sectional Study of 206 Patients (2015) (0)
- THU0133 Early Introduction of Biologic Treatment is an Important Predictor of Sustained Favorable Outcome Including Clinical Remission in Early Arthritis, but not of Sustained Favorable Outcome on Structure and Function Only: Results from the Espoir Cohort (2013) (0)
- OP0188 Defining clinically important worsening based on ASDAS-CRP for axial spondyloarthritis: a data-based consensus by the assessment in spondyloarthritis international society (ASAS) (2017) (0)
- AB0889 Association Between Clinically Meaningful Improvements in Patient-Reported Outcomes and Stringent Measures of Disease Activity in Patients With Psoriatic Arthritis Treated With Upadacitinib Versus Placebo or Adalimumab: Results From a Phase 3 Trial (2022) (0)
- OP0014 Care Patterns for Chronic Low Back Pain Patients Included in Functional Restoration Programs in France: Pejorative Professional Factors Delay Access (2014) (0)
- Etude des croyances liées aux modes de vie et leurs impacts sur la maladie chez 672 patients souffrant de polyarthrite rhumatoïde ou de spondyloarthrite axiale (2016) (0)
- THU0232 Is a positive family history of spondyloarthritis relevant for diagnosing axial spondyloarthritis once hla-b27 status is known? data from the asas, desir and space cohorts (2018) (0)
- OP0127 UNFAVORABLE PREGNANCY OUTCOME IS SIGNIFICANTLY ASSOCIATED WITH CORTICOSTEROID EXPOSURE DURING PREGNANCY IN WOMEN WITH RHEUMATOID ARTHRITIS: ANALYSIS OF THE PROSPECTIVE GR2 COHORT (2022) (0)
- 182 Secukinumab provides sustained improvement in function, quality of life and fatigue over two years in patients who achieved disease activity index for psoriatic arthritis remission (2018) (0)
- Challenges in interpreting sacroiliac magnetic resonance imaging for the diagnosis of axial spondyloarthritis. (2022) (0)
- Efficacy and Safety of Disease-Modifying Drugs in Psoriatic Arthritis (PsA): A Systematic Literature Review (2019) (0)
- Reply to the comment of Alkan Melikoglu 'Joint manifestations can provide diagnostic clues in Morquio syndrome, a case report'. (2019) (0)
- reviewin rheumatoid arthritis: a systematic literature Reporting of patient-reported outcomes in recent (2008) (0)
- POS1079 CLINICAL CHARACTERIZATION OF PRODROMAL AND VERY EARLY PSORIATIC ARTHRITIS: A SYSTEMATIC LITERATURE REVIEW FOR THE DEFINITION OF CLINICAL AND IMAGING SUSPICIOUS FEATURES FOR PROGRESSION TO PSORIATIC ARTHRITIS (2022) (0)
- Knowledge of and expectations about functional restoration programs for chronic low back pain: a mirror survey of 150 patients and 80 physicians in 2017. (2019) (0)
- P179 Shared decision-making in psoriatic arthritis consultations (2023) (0)
- THU0666 Patient global assessment is more sensitive to change than health-related quality of life instruments in early axial spondyloarthritis over 3 years: data from the desir cohort (2017) (0)
- SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENT IN FUNCTION, QUALITY OF LIFE AND FATIGUE OVER TWO YEARS IN PATIENTS WHO ACHIEVED LOW DISEASE ACTIVITY RELATED TO PSORIATIC ARTHRITIS DISEASE ACTIVITY SCORE (2018) (0)
- AB0529 CHARACTERIZATION OF REMISSION IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH UPADACITINIB: POST-HOC ANALYSIS FROM TWO PHASE 3 TRIALS (2021) (0)
- THU0593 Validity of The Bristol RA Fatigue Multi-Dimensional Questionnaire (BRAF-MDQ) and Rheumatoid Arthritis Impact of Disease (RAID) Scale across 6 European Countries (2016) (0)
- FRI0432 Well-being, sleep and coping had good psychometric properties in rheumatoid arthritis (RA): A subanalysis of an etanercept trial (2013) (0)
- THU0579 What Knowledge is Essential for Patients with Rheumatoid Arthritis (RA) and Spondyloarthritis (SPA)? Results of a Multicentric Survey Among Health Professionals and Patients with Delphi Methodology. An Initiative of the French Rheumatology Society Therapeutic Education Section (2015) (0)
- AB0841 TARGET OUTCOMES IN PsA: SIMULTANEOUS ACHIEVEMENT of ACR50-PASI100 AND BEYOND: INSIGHTS FROM SPIRIT-H2H AT WEEK 24 (2020) (0)
- SAT0573 Validity of The Short Form 6d Utility Measure in Early Axial Spondyloarthritis: Results from The Desir Cohort (2016) (0)
- Lifestyle Beliefs Of 672 Patients With Rheumatoid Arthritis Or Axial Spondyloarthritis (2016) (0)
- 28 OMERACT/OARSI INITIATIVE, STRUCTURE SEVERITY SCORING SYSTEM (2006) (0)
- SAT0377 DIFFERENCES IN CLINICAL CHARACTERISTICS, QUALITY OF LIFE, DISABILITY, AND WORK PRODUCTIVITY IN PSORIATIC ARTHRITIS PATIENTS BY GENDER: FINDINGS FROM A CROSS-SECTIONAL SURVEY IN THE US AND EUROPE (2019) (0)
- PAIN AND ANXIETY ARE INDEPENDENT FACTORS ASSOCIATED TO SLEEP IMPAIRMENT IN PSORIATIC ARTHRITIS: A MULTICENTRIC STUDY IN 14 COUNTRIES (2019) (0)
- SAT0367 PSAID9 IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS TREATED WITH FILGOTINIB VS PLACEBO: RESULTS FROM EQUATOR, A RANDOMIZED, PHASE 2 STUDY (2019) (0)
- Arrêts de travail dans la spondyloarthrite axiale : le questionnaire AS-WIS permet de prédire le risque d’arrêt de travail, étude longitudinale de 101 patients (2016) (0)
- Physical activity and barriers and facilitators in patients with rheumatoid arthritis or spondyloarthritis: a cross-sectional study of 150 patients (2021) (0)
- Perception de la rhumatologie par les étudiants en médecine et impact du stage clinique : résultats d’une étude mixte qualitative et quantitative (2021) (0)
- THU0393 Secukinumab provides sustained reduction in fatigue in patients with ankylosing spondylitis through 3 years: long-term results of two randomised double-blind placebo-controlled phase 3 studies (2017) (0)
- Reexamining remission definitions in rheumatoid arthritis: considering the 28‐joint Disease Activity Score, C‐reactive protein level, and patient global assessment: comment on the article by Felson et al (2021) (0)
- AB0819 FLARES AMONG PATIENTS WITH PSORIATIC ARTHRITIS (PsA) - FREQUENCY AND IMPACT ON PATIENT OUTCOMES: REAL-WORLD SURVEY IN THE US AND EUROPE (2020) (0)
- FRI0521 A framework and process to develop core outcome measurement sets for clinical trials in rheumatology: omeract filter 2.0 (2013) (0)
- SAT0664 RESPONSIVENESS OF PATIENT-REPORTED PHYSICAL FUNCTION OUTCOME MEASURES IN A REAL LIFE INTERNATIONAL COHORT OF 405 PATIENTS WITH PSORIATIC ARTHRITIS (2019) (0)
- AB0907 Treatment patterns in psoriatic arthritis in us and europe: results from a real-world international survey (2018) (0)
- POS1078 CURRENT REGISTRIES IN PSA DO NOT WELL REFLECT THE PROFILES OF PATIENTS WITH PsA BECAUSE THEY ORIGINATE IN SIMILAR COUNTRIES: A SYSTEMATIC LITERATURE REVIEW OF 27 REGISTRIES, OR 16183 PATIENTS (2021) (0)
- Results from the ESPOIR Cohort Study (2012) (0)
- La douleur fluctue chez la majorité des patients suivis pour une polyarthrite rhumatoïde ou une spondyloarthrite, surtout chez les femmes avec un niveau d’activité de la maladie élevé : une étude prospective de 12 semaines chez 165 patients (2021) (0)
- O24 Concomitant treatment with MTX does not increase the efficacy of ustekinumab or TFNi in PsA: results from the PsABio study (2020) (0)
- FRI0180 Multiple sclerosis risk-alleles study in patients with demyelinating side effects on anti tnf alpha therapy (2017) (0)
- 165. RESULTS OF THE EUROPEAN LEAGUE AGAINST RHEUMATISM TASK FORCE FOR STANDARDIZING A MINIMUM CORE DATASET FOR OBSERVATIONAL RESEARCH IN RHEUMATOID ARTHRITIS (2017) (0)
- 6 chronic diseases: a systematic literature review (2008) (0)
- SAT0576 Associations between Five Important Domains of Health and The Patient Acceptable Symptom State in Rheumatoid Arthritis and Psoriatic Arthritis: A Cross Sectional Study of 977 Patients (2016) (0)
- THU0538 Patients with chronic low back painoriented to functional restoration program are younger, with higher smoking and longer sick leave: a cross- sectional study of 166 patients (2018) (0)
- Patient-defined flares and disease activity worsening in 222 patients with psoriatic arthritis from 14 countries. (2022) (0)
- THU0418 Variable Selection is not Useful in the Construction of a Propensity Score for the Evaluation of TNF-Alpha Blockers' Treatment Effect of in Early Spondyloarthritis: Data from the DESIR Cohort (2014) (0)
- AB0756 Patients with Psoriatic Arthritis Have Strong Beliefs about the Etiology of Their Disease: A Systematic Literature Review (2014) (0)
- OP0098 POLYPHARMACY IS ASSOCIATED WITH A POORER TREATMENT RESPONSE AND INCREASED RISK OF ADVERSE EVENTS IN EARLY RHEUMATOID ARTHRITIS (2021) (0)
- AB1412 Nurses can achieve very good agreement with physicians for joint counts in rheumatoid arthritis – a feasible training method (2013) (0)
- SAT0081 Patient Involvement in Research is Widely Promoted but Practical Recommendations to Implement IT Are Heterogeneous: A Systematic Literature Review (2014) (0)
- The Journal of Rheumatology of 234 Patients Patient-reported Flares in Ankylosing Spondylitis: A Cross-sectional Analysis (2016) (0)
- OP0244-PARE The Medication Workshop Tool Kit: A Patient League Project Targeting Drug Safe Use (2014) (0)
- THU0135 PATIENT GLOBAL ASSESSMENT LEVELS PRECLUDE THE MAJORITY OF RHEUMATOID ARTHRITIS PATIENTS OTHERWISE IN REMISSION, FROM REACHING THIS STATUS: SYSTEMATIC LITERATURE REVIEW AND META-ANALYSES INCLUDING 23,297 PATIENTS (2020) (0)
- Chapter 7 Difference in the association between obesity and pain in hip and knee osteoarthritis (2013) (0)
- Traiter le rhumatisme psoriasique : que proposent les rhumatologues ? Recommandations européennes 2020 (2020) (0)
- THU0602 Patient Global Assessment in Rheumatoid Arthritis Conveys A Variable Blend of Disease Activity and Disease Impact: A Cross-Sectional Study with 311 Patients (2016) (0)
- THU0588 Are rheumatoid arthritis patients willing to use an e-health interactive self-assessment website? analyses of 159 patients from a randomised controlled trial over 12 months (2017) (0)
- THU0378 How Frequent Were Patient Reported Flares in Ankylosing Spondylitis Patients before The Wide Use of antiTNF and What Is The Validity of Patient Reported Flares? A Cross-Sectional Analysis of 234 Patients (2016) (0)
- THU0134 Favorable Outcome, a New Concept for the Evaluation of Health Status in Rheumatoid Arthritis (RA) not so Easy to Achieve: Results from the Espoir Cohort (2013) (0)
- SAT0654 SHOULD PATIENTS WITH RHEUMATOID ARTHRITIS (RA) ASK FOR A BETTER DEAL THAN MERELY AN ACCEPTABLE SYMPTOM STATE? AN ANALYSIS OF 1931 RA PATIENTS (2019) (0)
- When and for how long glucocorticoids in rheumatoid arthritis: international guidelines and recommendations (2014) (0)
- SP0156 Latest Advances in Biological Treatment – Safety and Efficacy (2013) (0)
- Response to: ‘Additional proposals to reduce comorbidity in patients with chronic inflammatory rheumatic diseases’. Screening for comorbidities: what is the remit of rheumatologists? (2016) (0)
- FRI0538 Development and Validation of a Questionnaire for the Identification of Different Behavioral Strategies in Patients with Chronic Low Back Pain (2015) (0)
- POS1021 THE PsABio STUDY IN ITALY: A REAL-WORLD COMPARISON OF THE PERSISTENCE, EFFECTIVENESS AND SAFETY OF USTEKINUMAB AND TUMOUR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH PSORIATIC ARTHRITIS (2021) (0)
- SAT0399 The Patient-Derived PSA Impact of Disease (PSAID) Questionnaire Correlates with Other Outcome Measures: HÜR-BİO REAL Life Results (2014) (0)
- THU0675 Development and psychometric validation of a tool to assess the fears of patients with chronic inflammatory rheumatic diseases: the fair scale (2017) (0)
- SAT0679 EFFICACY OF A NURSE-LED PATIENT EDUCATIONINTERVENTION IN PROMOTING SAFETY KNOWLEDGE AND SKILLS OF PATIENTS WITH INFLAMMATORY ARTHRITIS (IA) TREATED WITH BIOLOGICS: A RANDOMIZED CONTROLLED TRIAL (2019) (0)
- POS1000 MORE THAN 30 % OF WOMEN WITH SPONDYLOARTHRITIS HAVE AN UNFAVORABLE PREGNANCY OUTCOME MOST FREQUENTLY DUE TO SMALL FOR GESTATIONAL AGE: ANALYSIS OF THE PROSPECTIVE GR2 COHORT (2022) (0)
- AB0765 Secukinumab provides sustained improvement in function, quality of life and fatigue over 2 years in patients who achieved disease activity index for psoriatic arthritis (DAPSA) remission (2017) (0)
- Sensibilité et spécificité des différentes localisations des érosions de la main pour distinguer les patients atteints de polyarthrite rhumatoïde des contrôles à l’IRM et à la TDM : une analyse de 90 sujets (2016) (0)
- THU0096 REVISITING THE REMISSION CRITERIA FOR RHEUMATOID ARTHRITIS BY EXCLUDING PATIENT GLOBAL ASSESSMENT: AN INDIVIDUAL PATIENT META-ANALYSIS INCLUDING 5792 PATIENTS (2020) (0)
- SP0007 The Total Knee Prosthesis as Ultimate (At Least Final) Outcome Measure in OA Trials (2014) (0)
- SAT0056 What Are The Reasons of Discrepancies between Patients and Physicians in Their Perceptions of Rheumatoid Arthritis Disease Activity and What Is The Impact of This Discordance on Remission, Function and Structure at 1 Year? Results from The ESPOIR Cohort (2016) (0)
- AB0269 Favorable outcome, a new concept for the evaluation of health state in rheumatoid arthritis (RA): results from the french ESPOIR cohort (2013) (0)
- THU0483 Characteristics of patients with active axial spondyloarthritis and comorbid fibromyalgia. differences according to fibromyalgia screening (first questionnaire) and fibromyalgia classification (ACR1990) (2017) (0)
- Persistence, effectiveness and safety of ustekinumab compared to TNF inhibitors in psoriatic arthritis within the Italian PsABio cohort. (2022) (0)
- SAT0337 Biologic dmards and psoriatic arthritis in europe in 2016/2017: characteristics of patients starting tnf-inhibitors or ustekinumab in the ongoing psabio observational cohort study (2018) (0)
- OP0249 CHARACTERISTICS ASSOCIATED WITH POOR COVID-19 OUTCOMES IN PEOPLE WITH PSORIASIS AND SPONDYLOARTHRITIS: DATA FROM THE COVID-19 PsoProtect AND GLOBAL RHEUMATOLOGY ALLIANCE PHYSICIAN-REPORTED REGISTRIES (2022) (0)
- Le dépistage et la prévention des comorbidités dans la polyarthrite rhumatoïde (PR) après un programme d’information par infirmier : suivi à 3 ans de 769 patients atteints de PR établie de l’étude COMEDRA (2016) (0)
- SAT0356 Discriminant Capacity of Clinical Efficacy Measures, Alone or in Combination with NSAID Intake, in Detecting Anti-TNF Treatment Effect in Spondyloarthritis (2014) (0)
- THU0152 Who are the patients with rheumatoid arthritis (RA) who are getting comorbidity screening procedures in accordance with guidelines? a study of 769 established ra patients (2017) (0)
- SP0074 The future of epidemiological research in rheumatic and musculoskeletal disorders (2017) (0)
- POS1080 CHARACTERIZATION OF JOINT DISTRIBUTION AND DISEASE BURDEN IN PATIENTS WITH EARLY OLIGOARTICULAR PSORIATIC ARTHRITIS: RESULTS FROM THE ONGOING FOREMOST STUDY (2022) (0)
- OP0074 A FRAMEWORK OF POTENTIAL INTERVENTIONS TO ACCELERATE GENDER-EQUITABLE CAREER ADVANCEMENT IN ACADEMIC RHEUMATOLOGY (2021) (0)
- Country-Level Factors Associated With COVID-19-Related Death in People With Rheumatic Disease: Results From the COVID-19 Global Rheumatology Alliance Registry (2022) (0)
- FRI0720-HPR DEVELOPMENT AND VALIDATION OF A SELF-ADMINISTRATED QUESTIONNAIRE MEASURING ESSENTIAL KNOWLEDGE FOR PATIENTS WITH RHEUMATOID ARTHRITIS: THE RHEUMATOID ARTHRITIS ASSESSMENT KNOWLEDGE QUESTIONNAIRE (RAKE) (2019) (0)
- FRI0437 PATIENT-DEFINED FLARES IN IN PSORIATIC ARTHRITIS: WHAT DO THEY MEAN? AN ANALYSIS OF CHANGE BETWEEN 2 VISITS IN 222 PATIENTS (2019) (0)
- EULAR points to consider for including the perspective of young patients with inflammatory arthritis into patient-reported outcomes measures (2022) (0)
- Correction to: Measuring treatment effect on psoriatic arthritis-related domains: insights from the SPIRIT-H2H study at weeks 24 and 52 (2021) (0)
- Gender-specific differences in patients with psoriatic arthritis receiving ustekinumab or tumour necrosis factor inhibitor: real-world data. (2023) (0)
- Interpreting the efficacy of secukinumab on patient-reported outcomes in psoriatic arthritis (2022) (0)
- Prediction of Work Impact in Axial Spondyloarthritis by the Work Instability Scale: A Prospective Cohort Study of 101 Patients (2020) (0)
- THU0482 Evolution of comorbid fibromyalgia frequency in axial spondyloarthritis patients starting an anti-tnf agent, and correlation to anti-tnf efficacy. the predict-spa study (2017) (0)
- SAT0332 Disease Activity Trajectories in Early Axial Spondyloarthritis: Results from the Desir Cohort (2015) (0)
- The influence of sex on early axial spondyloarthritis, 6-year longitudinal analyses from a large national cohort. (2023) (0)
- POS0621 MORE THAN 40% OF WOMEN WITH RHEUMATOID ARTHRITIS HAVE A TIME-TO-CONCEPTION LONGER THAN 1 YEAR: ANALYSIS OF THE PROSPECTIVE GR2 COHORT (2022) (0)
- Clinical measurement of disease activity in rheumatoid arthritis: why, how and utility of patient self-assessment (2014) (0)
- FRI0155 Fifty Percent of Patients Who Tapered TNF-Blockers while in Stable Remission Are Able To Maintain A Tapered Regimen at 3 Year: Long Term Follow-Up Extension of The Strass Trial (2016) (0)
- AB1135 Preliminary Definitions of “Flare” in Axial Spondyloarthritis, Based on Pain, Basdai and ASDAS-CRP: An Asas Initiative (2015) (0)
- FRI0467 Is fatigue discriminant in early spondyloarthritis (SPA)? the desir early spa cohort (2013) (0)
- Corrélation entre amélioration des résultats rapportés par le patient (PRO) et mesures strictes de l’activité de la maladie chez des patients atteints de rhumatisme psoriasique et traités par upadacitinib versus placebo ou adalimumab (2021) (0)
- SP0202 WHAT DOES REMISSION MEAN FOR PHYSICIANS? (2019) (0)
- POS0607 IMPROVING TREAT-TO-TARGET IMPLEMENTATION IN RHEUMATOID ARTHRITIS: A SYSTEMATIC LITERATURE REVIEW OF BARRIERS, FACILITATORS, AND INTERVENTIONS (2022) (0)
- AB0335 Are eular rheumatoid arthritis (RA) management recommendations applicable at the country level? similarities and differences with the recent french ra management recommendations (2018) (0)
- SAT0432 EFFECT OF SEX ON DISEASE CHARACTERISTICS AND DISEASE IMPACT IN PATIENTS WITH PSORIATIC ARTHRITIS (PsA): INSIGHTS FROM THE REAL-WORLD, OBSERVATIONAL MULTINATIONAL PsABio COHORT (2020) (0)
- POS1076 OBESITY IS ASSOCIATED WITH LESS LIKELIHOOD OF REMISSION/ LOW DISEASE IN PSORIATIC ARTHRITIS, A CROSS-SECTIONAL STUDY OF 414 PATIENTS (2022) (0)
- Clinical significance of a self-reported familial occurrence of rheumatoid arthritis among patients with recent-onset arthritis: data from the ESPOIR cohort. (2022) (0)
- FRI0415 Being younger and living with a partner are important determinants of sustained favorable outcome in early arthritis (EA): Results from the french espoir cohort (2013) (0)
- Instruments Through Assessment of ''Truth'': Content, Face, and Construct Updating the OMERACT Filter: Implications of Filter 2.0 to Select Outcome (2014) (0)
- FRI0047 The Patient Perspective on Absence of Disease Activity in Rheumatoid Arthritis: A Survey to Identify Key Domains of Patient Perceived Remission (2015) (0)
- FRI0519 Effect of biologics on fatigue in psoriatic arthritis: a systematic literature review with meta-analysis (2017) (0)
- THU0116 Efficacy of Glucocorticoids for Early Rheumatoid Arthritis (RA): A Meta-Analysis of Randomised Controlled Trials (2014) (0)
- SAT0367 EXTRA-ARTICULAR MANIFESTATIONS IN EARLY AXIAL SPONDYLOARTHRITIS: WHAT IS THEIR FREQUENCY? A SYSTEMATIC LITERATURE REVIEW INCLUDING 2854 PATIENTS (2020) (0)
- SP0084 Patient involvement in research on the international arena (2013) (0)
- OP0240-PARE Announce and explain ankylosing spondylitis, creation of a patient tool (2013) (0)
- 433 IMPROVEMENT OF THE REPRODUCIBILITY OF THE RADIOGRAPHIC KELLGREN-LAWRENCE (KL) SCORING SYSTEM IN HAND OSTEOARTHRITIS (HOA) USING A NEW KL SCORING SYSTEM AID (2010) (0)
- AB1018 Does Fatigue Improve in A Similar Manner To Pain in Patients with Rheumatoid Arthritis (RA) Treated with A Biologic? A Reanalysis of Randomized Controlled Trials of Abatacept in 1536 Patients with Active RA (2016) (0)
- THU0451 The Formulation of the Patient Global Assessment Question Influences the Classification of Patients with Rheumatoid Arthritis (RA) into Acr/Eular Remission: an Analysis of Patients Enrolled in ESPOIR and Comedra (2014) (0)
- FRI0036 Failing to Achieve Low Disease Activity during the First Year of Early Arthritis is an Independent Predictor of Work Disability at 5 Years: Results from the ESPOIR Cohort (2014) (0)
- AB0550 EFFICACY OF UPADACITINIB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND A LOW OR HIGH SWOLLEN JOINT COUNT: A SUBGROUP ANALYSIS OF 2 PHASE 3 STUDIES (SELECT-PsA 1 AND SELECT-PsA 2) (2021) (0)
- Perception des poussées de polyarthrite rhumatoïde telles que rapportées par les patients : sous-analyse de l’essai STRASS sur les stratégies de diminution progressive du traitement (2017) (0)
- SAT0365 Who Are the Spondyloarthritis Patients with A Primary Inefficacy of A First TNF Blocker? A Monocenter Systematic Study (2014) (0)
- 289 MAGNITUDE OF THE SYMPTOMATIC AT 3, 6 AND 12 MONTHS AFTER TOTAL ARTICULAR REPLACEMENT IN HIP AND KNEE OSTEOARTHRITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS (2008) (0)
- Efficacité du sécukinumab chez les patients atteints de rhumatisme psoriasique avec manifestations axiales : efficacité clinique et IRM à 52 semaines dans l’essai randomisé contrôlé MAXIMISE (2020) (0)
- Development and Validation of a Self-Administered Questionnaire Measuring Essential Knowledge in Patients With Axial Spondyloarthritis (2022) (0)
- Long-term effectiveness and persistence of ustekinumab and TNF inhibitors in patients with psoriatic arthritis: final 3-year results from the PsABio real-world study (2022) (0)
- POS1025 TOFACITINIB TREATMENT IN PATIENTS WITH PSORIATIC ARTHRITIS AND PROBABLE DEPRESSION AND/OR ANXIETY: A POST HOC ANALYSIS OF TWO PHASE 3 CLINICAL TRIALS (2021) (0)
- Traitement par le rituximab des vascularites systémiques associées à la polyarthrite rhumatoïde. Données du registre AIR (2012) (0)
- AB0527 CORRELATIONS BETWEEN REDUCTIONS IN FATIGUE SEVERITY AND IMPROVEMENTS IN PHYSICAL FUNCTION AND CLINICAL RESPONSE IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM THE PHASE 3 DISCOVER PROGRAM (2021) (0)
- AB0530 EFFECT OF SKIN SYMPTOMS ON DISEASE IMPACT IN PATIENTS WITH PSORIATIC ARTHRITIS RECEIVING THE IL-12/23 INHIBITOR USTEKINUMAB OR TNF INHIBITORS IN THE REAL-WORLD PSABIO STUDY (2021) (0)
- OP0288 MACHINE LEARNING ALGORITHMS TO PREDICT COVID-19 ACUTE RESPIRATORY DISTRESS SYNDROME IN PATIENTS WITH RHEUMATIC DISEASES: RESULTS FROM THE GLOBAL RHEUMATOLOGY ALLIANCE PROVIDER REGISTRY (2021) (0)
- Collecte et prise en charge de certaines comorbidités et facteurs de risque associés dans le cadre des rhumatismes inflammatoires chroniques dans la pratique quotidienne en France (2017) (0)
- FRI0106 The Association of Fatigue, Comorbidities and Anti Rheumatic Drugs in Rheumatoid Arthritis: Results from The Comedra Study (2016) (0)
- FRI0605 The development process of mobile health applications for self-management in patients with rheumatic and musculoskeletal diseases is heterogeneous and often incomplete: results of a systematic literature review (2018) (0)
- POS1038 GUSELKUMAB EFFICACY IN PSORIATIC ARTHRITIS ASSESSED BY MULTI-DOMAIN COMPOSITE INDICES: DATA FROM THE PHASE 3B COSMOS TRIAL IN A TNFi-IR POPULATION (2022) (0)
- P178 Current prescribing practices in psoriatic arthritis - comparison between the UK and Europe (2023) (0)
- SAT0608-HPR EULAR POINTS TO CONSIDER FOR THE DETECTION, ASSESSMENT AND MANAGEMENT OF NON-ADHERENCE IN PEOPLE WITH RHEUMATIC AND MUSCULOSKELETAL DISEASES (2020) (0)
- FRI0473 Patient-physician discordance in global assessment in 401 early axial spondyloarthritis (AXSPA) patients from the desir cohort: what is the effect on outcomes at 3 years? (2017) (0)
- PARE0016 IMPACT OF AXIAL SPONDYLOARTHRITIS ON PATIENTS’ PROFESSIONAL LIFE: RESULTS FROM THE ONLINE SURVEY EMAS OF 638 FRENCH PATIENTS (2019) (0)
- Association Between Race/Ethnicity and COVID‐19 Outcomes in Systemic Lupus Erythematosus Patients From the United States: Data From the COVID‐19 Global Rheumatology Alliance (2022) (0)
- Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries (2023) (0)
- POS1046 IMPROVEMENTS IN PATIENT-REPORTED IMPACT OF PSORIATIC ARTHRITIS WITH IL-12/23 (USTEKINUMAB) OR TUMOUR NECROSIS FACTOR INHIBITORS: 1-YEAR DATA FROM THE LARGE, REAL-WORLD PsABIO STUDY (2021) (0)
- Agreement with the French 2019 recommendations on treatment adherence among 357 health professionals. (2020) (0)
- Diagnosis of Giant Cell Arteritis : Analysis of 77 Subjects Limited Value of Temporal Artery Ultrasonography Examinations for GUILLEVIN (2010) (0)
- FRI0315 GENDER DIFFERENCES IN PATIENT JOURNEY TO DIAGNOSIS AND PATIENT-REPORTED OUTCOMES: RESULTS FROM THE EUROPEAN MAP OF AXIAL SPONDYLOARTHRITIS (EMAS) (2020) (0)
- THU0358 DEVELOPMENT OF A SET OF ASAS QUALITY STANDARDS FOR ADULTS WITH AXIAL SPONDYLOARTHRITIS (2019) (0)
- Développement et validation d’un questionnaire identifiant différentes stratégies comportementales chez les patients lombalgiques chroniques (2017) (0)
- AB1413 PHA-BRIC: Therapeutic information of rheumatology patients receiving biologics in cochin hospital (2013) (0)
- Persistance similaire sur 15 mois de l’ustékinumab (UST) et des anti-TNF chez les patients atteints de rhumatisme psoriasique (RP) : étude PsABio multicentrique en vraie vie (2020) (0)
- THU0346 Concomitant fibromyalgia in axial spondyloarthritis has a negative impact on tnf alpha blockers treatment effect in real life (2017) (0)
- FRI0052 Large Joint Involvement in Asian Rheumatoid Arthritis Patients: A Longitudinal Study of Treatment Outcomes Using Power Doppler as a Bedside Monitoring Tool in 101 Patients (2015) (0)
- P174 Psoriatic arthritis patients in the UK have a lower quality of life than patients in mainland Europe - an analysis from the ASSIST study (2023) (0)
- Erratum to "2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis" [Joint Bone Spine 2022;89:105344]. (2022) (0)
- AB1202 The Country Where You Perform Your Rheumatology Training is Associated with the Acquired Confidence, The Education Received and the Assessments in Core Competences (2015) (0)
- FRI0465 Angles of sacrum inclination effect on radiologic imaging reading in spondyloarthritis (the antelope-desir study) (2017) (0)
- FRI0578 Is the Localisation of Erosions on MRI of Diagnostic Interest in Rheumatoid Arthritis? (2015) (0)
- FRI0182 Erosions at the sacroiliac joints and fatty lesions at the spine are the most discriminant lesions for recent onset axspa recognition (2018) (0)
- Impact of Physician-Defined Flares on Quality of Life and Work Impairment: An International Survey of 2238 Patients With Psoriatic Arthritis (2022) (0)
- Impact of key manifestations of psoriatic arthritis on patient quality of life, functional status, and work productivity: findings from a real-world study in the United States and Europe. (2023) (0)
- AB0818 SKIN INVOLVEMENT IN PSORIATIC ARTHRITIS (PsA) - THE INCREMENTAL IMPACT OF PSORIASIS ON QUALITY OF LIFE, DISABILITY AND WORK PRODUCTIVITY: REAL-WORLD SURVEY IN US AND EUROPE (2020) (0)
- Efficacy of Ixekizumab in Different Phenotypes of Patients with Active Psoriatic Arthritis (PsA): Results from the Spirit Trials (2018) (0)
- FRI0095 SARILUMAB IMPROVED PATIENT-PERCEIVED IMPACT OF RHEUMATOID ARTHRITIS WHATEVER THE BASELINE DISEASE ACTIVITY: FIRST RESULTS FROM AN INTERVENTIONAL NON CONTROLLED STUDY: SARIPRO, IN MODERATE AND SEVERE RHEUMATOID ARTHRITIS PATIENTS (2020) (0)
- POS1017 GUSELKUMAB PROVIDES CONTINUED IMPROVEMENT IN KEY DOMAINS OF PSORIATIC ARTHRITIS THROUGH 2 YEARS (2022) (0)
- SAT0328 PATIENT-REPORTED ATTITUDES TOWARDS AXIAL SPONDYLOARTHRITIS: RESULTS FROM THE EMAS SURVEY (2019) (0)
- 294 COMPARISON OF THE PSYCHOMETRIC PROPERTIES OF THE OARSI-OMERACT VS WOMAC PAIN AND FUNCTION QUESTIONNAIRES IN HIP AND KNEE OSTEOARTHRITIS (2009) (0)
- SAT0668 “WHEN YOU READ THIS, YOU REALLY FEEL OLD!” PERSPECTIVES OF YOUNG PEOPLE WITH INFLAMMATORY ARTHRITIS ON PATIENT REPORTED OUTCOME MEASURES FROM A EUROPEAN QUALITATIVE STUDY (2019) (0)
- Diagnostic et suivi des spondylarthropathies (SA) : le point de vue du rhumatologue (2009) (0)
- FRI0432 Clinical worsening according to the patient is infrequent in axial spondyloarthritis: results of the asas-flare study in 1169 patients (2017) (0)
- Risque cardiovasculaire et polyarthrite rhumatoïde : établissement de recommandations pour la pratique clinique à partir de données de la littérature et d'opinions d'experts (2005) (0)
- POS0305 TIME TO IMPROVEMENT OF FATIGUE IN PATIENTS WITH ANKYLOSING SPONDYLITIS IN A STUDY OF TOFACITINIB (2022) (0)
- Efficacité du rituximab en pratique quotidienne: essai ouvert chez des patients avec polyarthrite rhumatoïde réfractaire ou contre-indications aux anti-TNFalpha (2006) (0)
- Les articles récents d'études dans la polyarthrite rhumatoïde (PR) ne rapportent pas les critères reflétant l'opinion du patient. Une revue systématique de la littérature (2007) (0)
- There is a risk of overtreatment when the Disease Activity Score in 28 joints is based solely on subjective parameters . A cross-sectional , exploratory , DANBIO study (2016) (0)
- FRI0052 INFLUENCE OF RHEUMATOID ARTHRITIS ON THE CLINICAL AND BIOLOGICAL PROFILE OF TYPE-2 DIABETES MELLITUS (2020) (0)
- AB0694 Rheumatologists' attribution of patient-reported symptoms in axial spondyloarthritis (AXSPA): impact on response to TNF-inhibitors (TNFI) in 508 patients (2017) (0)
- OP0102 Patient reported benefits of sarilumab monotherapy versus adalimumab monotherapy in adult patients with active rheumatoid arthritis (2017) (0)
- Development and validation of a questionnaire to assess facilitators and barriers to physical activity for patients with rheumatoid arthritis, axial spondyloarthritis or psoriatic arthritis (2020) (0)
- SAT0385 Is interleukine-6 a better surrogate biomarker of persistent joint inflammation than C-reactive protein in early arthritis? Results from the espoir cohort (2013) (0)
- Délai d’amélioration de la fatigue chez les patients atteints de spondylarthrite ankylosante dans une étude sur le tofacitinib (2022) (0)
- SAT0653 PATIENT-ACCEPTABLE SYMPTOM STATUS IN RHEUMATOID ARTHRITIS: WEALTH AND AGE MATTER BEYOND DISEASE ACTIVITY AND IMPACT. AN ANALYSIS OF 548 PATIENTS (2019) (0)
- AB0821 ANXIETY AND DEPRESSION IN PSORIATIC ARTHRITIS (PsA) - PREVALENCE AND IMPACT ON PATIENT REPORTED OUTCOMES: REAL-WORLD SURVEY IN THE US AND EUROPE (2020) (0)
- OP0298 ARE PATIENTS WITH PSORIATIC ARTHRITIS BEING TREATED OPTIMALLY ACROSS THE WORLD? DISPARITIES IN HEALTH CARE FOR PATIENTS WITH PSORIATIC ARTHRITIS ACROSS COUNTRIES WITH DIFFERENT GDP’S, AN ANALYSIS OF 429 PATIENTS FROM 13 COUNTRIES (2021) (0)
- AB1274 OF 60 PUBLICATIONS REFERRING TO BIG DATA IN RHEUMATIC AND MUSCULOSKELETAL DISEASES, 33 APPLIED ARTIFICIAL INTELLIGENCE STATISTICAL TECHNIQUES: A SYSTEMATIC LITERATURE REVIEW INFORMING A EULAR TASKFORCE (2019) (0)
- FRI0654 Is the patient-acceptable status similar across 7 domains of health in patients with rheumatoid arthritis (RA)? post-hoc analyses from the validation in 549 patients of the rheumatoid arthritis impact of disease (RAID) score (2018) (0)
- Response to: ‘The GRAPPA-OMERACT initiative to standardise outcomes in Psoriatic Arthritis clinical trials and longitudinal observational studies’ by Tillet et al (2017) (0)
- The Journal of Rheumatology OMERACT Delphi Survey and Consensus Meeting Shared Decision-making Interventions in Rheumatology : Results from an Toward the Development of a Core Set of Outcome Domains to Assess (2017) (0)
- AB0791 Why Do Patients with Axial Spondyloarthritis (AXSPA) Perform Little Aerobic Exercise? A Study of Perceived Barriers and Benefits in 153 Axspa Patients (2015) (0)
- Functional restoration programs in patients with chronic low back pain and body composition: No change in muscle mass assessed through Dual X-ray absorptiometry in 94 patients, a monocenter longitudinal study. (2016) (0)
- FRI0243 Bone Mineral Density in Ankylosing Spondylitis: Meta-Analysis of Retrospective Observational Data from 3420 Subjects (2015) (0)
- Impact of Axial Spondyloarthritis on Quality of Life: Results From the European Map of Axial Spondyloarthritis (EMAS) Study in France (2022) (0)
- OP0246-PARE Health Democracy in Rheumatoid Arthritis and Spondyloarthritis – A Practical Application to Management Recommendations in France (2015) (0)
- Maintien à 3 ans de la stratégie de décroissance des anti-TNF dans la polyarthrite rhumatoïde : suivi de l’étude randomisée et contrôlée STRASS (Spacing of TNF-blocker injections in Rheumatoid ArthritiS Study) (2016) (0)
- Le sexe influence-t-il le devenir des patients dans la spondylarthrite axiale ? - une analyse sur 6 ans de la cohorte DESIR (2021) (0)
- Compléments : Que signifie l’évaluation globale par le patient dans le rhumatisme psoriasique ? Une analyse de 223 patients issus de l’étude d’élaboration du Psoriatic Arthritis Impact of Disease (PsAID) (2017) (0)
- Etude de deux polymorphismes prédisposant à la SEP chez des patients ayant des complications démyélinisantes liées au traitement par anti-TNF alpha (2016) (0)
- Les patients ayant une polyarthrite rhumatoïde ou une spondylarthrite axiale se déclarent en poussée persistante dans 8 % des évaluations hebdomadaires sur 3 mois : étude observationnelle de 165 patients (2016) (0)
- Les réseaux de soins peuvent être une base pour l'évaluation des pratiques professionnelles: expérience du réseau RHEVER sur les données écrites des dossiers patients (2009) (0)
- Analyse de la marche comme critère de suivi dans la coxarthrose ou la gonarthrose : analyse systématique de la littérature (2010) (0)
- Utilisation du méthotrexate dans la polyarthrite rhumatoïde : établissement de recommandations pour la pratique clinique à partir de données de la littérature et d'opinions d'experts (2005) (0)
- Quelle est la validité du concept de poussée rapportée par le patient dans la spondylarthrite ankylosante et quelle était la fréquence de ces poussées avant l’ère des anti-TNF ? Analyse transversale de 234 patients (2016) (0)
- Indices et critères en rhumatologie : la suite… mais pas la fin ! (2010) (0)
- Critères d’évaluation à collecter pour optimiser la prise en charge de routine de la spondyloarthrite axiale : proposition fondée sur des preuves et une rencontre d’experts (2021) (0)
- Accord de 357 professionnels de santé avec les recommandations des Rencontres d’Experts 2019 sur l’adhésion médicamenteuse (2021) (0)
- Le bimékizumab améliore la qualité de vie chez les patients atteints de rhumatisme psoriasique actif, naïfs de biologiques ou avec réponse inadéquate aux anti-TNF : résultats à 16 semaines de 2 études de phase III randomisées, contrôlées par placebo (2022) (0)
- Appariement probabiliste au système national des données de santé (SNDS) d'une cohorte de patients ayant des symptômes évocateurs d'une spondyloarthrite axiale récente, la cohorte DESIR (2022) (0)
- Impact de la spondyloarthrite axiale sur la qualité de vie : résultats de l’étude European Map of Axial Spondyloarthritis (EMAS) chez 638 patients en France (2021) (0)
- Evolution des lésions radiographiques dans la polyarthrite rhumatoïde en rémission (2006) (0)
- Le diagnostic de spondylarthrite en 2009: nouveaux critères et place de l'IRM (2009) (0)
- Latest Highlights on Biologic Treatments for Psoriatic Arthritis from EULAR 2021 (2020) (0)
- Pratiques et croyances alimentaires des patients atteints de maladies rhumatismales et relation avec les symptômes : résultats d’une étude transversale multicentrique (2022) (0)
- L’uvéite antérieure aigue dans la spondyloarthrite : une étude monocentrique de 301 patients (2016) (0)
- OP0011 Does a very early therapeutic intervention in very early arthritis / pre-rheumatoid arthritis patients prevent the onset of rheumatoid arthritis: a systematic review and metanalysis (2017) (0)
- Prévalence et conséquences du psoriasis sur les spondyloarthrites axiales récentes : une analyse de 589 patients sur 6 ans (2021) (0)
- Augmentation du risque de fractures vertébrales chez les femmes ménopausées traitées par oméprazole (2007) (0)
- Evaluation de l'efficacité et de la tolérance des opioïdes dans la gonarthrose et la coxarthrose: revue systématique de la littérature (2006) (0)
- Le maintien du traitement était similaire à 3 ans chez les patients atteints de rhumatisme psoriasique traités par ustékinumab ou par un anti-TNF, dans une étude prospective en vraie vie (2021) (0)
- Le savoir nécessaire aux patients atteints de polyarthrite rhumatoïde ou de spondyloarthrite. Résultats d’une enquête multicentrique française auprès de professionnels de santé et de patients (2020) (0)
- Dépression et anxiété chez des patients souffrant d’un rhumatisme psoriasique traités par tofacitinib : analyse post-hoc de deux essais cliniques de phase 3 (2021) (0)
- Facteurs prédictifs de réponse au sécukinumab chez les patients atteints de rhumatisme psoriasique avec manifestation axiale : analyse post-hoc de l’essai randomisé contrôlé MAXIMISE (2021) (0)
- Les programmes de réentraînement à l’effort chez les patients lombalgiques chroniques et la composition corporelle : pas de variation de la masse musculaire évaluée à partir de l’absorptiométrie à rayon X. Étude monocentrique longitudinale chez 94 patients (2017) (0)
- Identification de trajectoires d’activité dans la spondyloarthrite axiale récente : résultats de la cohort DESIR (2020) (0)
- Améliorations de l’impact rapporté par les patients du rhumatisme psoriasique sous IL-12/23 (ustékinumab) et sous anti-TNF : données à un an de l’étude PsABio en vie réelle (2021) (0)
- Iconography : le point sur… - Comment je fais un bilan échographique des mains et des pieds dans la polyarthrite rhumatoïde ? (2010) (0)
- Validité de la mesure d’utilité SF-6D dans la spondyloarthrite axiale débutante : Résultats de la cohorte DESIR (2016) (0)
- OP0245-PARE Helping Patients to Make Informed Decisions. The Pare Guide to Disseminate Eular Recommendations Among Patients (2015) (0)
- Utilisation des anti-inflammatoires non-stéroïdiens dans la spondylarthrite axiale débutante en pratique quotidienne : données de la cohorte DESIR (2017) (0)
- Infiltrations intra-articulaires dans la rhizarthrose : revue systématique et méta-analyse d’essais comparatifs randomisés (2016) (0)
- Influence de l’expérience du lecteur sur la variabilité de mesure de l’interligne articulaire : étude transversale portant sur des lectures répétées de radiographies dans la coxarthrose (2011) (0)
- Evaluation des pratiques professionnelles en consultation de rhumatologie (2007) (0)
- Tolérance de la vaccination contre le SRAS-CoV-2 chez les patients atteints de maladies rhumatologiques inflammatoires/auto-immunes : résultats du registre EULAR-COVAX chez 5121 patients (2021) (0)
- Appariement probabiliste au système national des données de santé (SNDS) d’une cohorte de patients ayant des symptômes évocateurs d’une spondyloarthrite axiale récente : la cohorte DESIR (2020) (0)
- Compétences et besoins éducatifs rapportés par les infirmiers de rhumatologie : résultats d’une enquête nationale française (2020) (0)
- Évaluation des préjugés des étudiants en Médecine sur les rhumatismes handicapants : une expérience pilote incluant des « focus groups » suivis d’interactions avec des associations de patients (2016) (0)
- Les mucopolysaccharidoses vues chez l’adulte en rhumatologie (2018) (0)
- Critères composites en rhumatologie (2008) (0)
- le point sur… - Comment je fais un bilan échographique des mains et des pieds dans la polyarthrite rhumatoïde ? (2010) (0)
- Caractérisation de la rémission chez des patients atteints de rhumatisme psoriasique traités par upadacitinib : analyse post hoc de deux essais de phase 3 (2020) (0)
- L’impact du rhumatisme psoriasique : lien entre les domaines d’impact importants pour les patients souffrant de rhumatisme psoriasique et la Classification Internationale du Fonctionnement, du Handicap et de la Santé (ICF) (2016) (0)
- Les questionnaires d'adhésion aux traitements de fond dans les rhumatismes inflammatoires chroniques et leurs propriétés psychométriques: une revue systématique de la littérature (2021) (0)
- Les critères d'évaluation rapportés par le patient dans la polyarthrite rhumatoïde (2010) (0)
- Étude Pha-Bric : évaluation de la satisfaction des patients sous biothérapies après entretien pharmaceutique (2012) (0)
- AB0786 Systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: a grappa-omeract initiative (2017) (0)
- La fatigue dans le rhumatisme psoriasique. Étude transversale portant sur 246 patients de 13 pays (2017) (0)
- Numérique et activités physiques en rhumatologie (2021) (0)
- Quelle est l’acceptabilité d’un bracelet connecté sur 3 mois chez 177 patients ayant une polyarthrite rhumatoïde ou une spondylarthrite axiale ? (2016) (0)
- Impact des comorbidités sur la fatigue dans la polyarthrite rhumatoïde : Résultats d’un programme infirmier de prise en charge des comorbidités (COMEDRA) (2019) (0)
- Le rhumatisme psoriasique : un sujet en évolution ! (2020) (0)
- L’hétérogénéité des outils d’évaluation de l’activité du rhumatisme psoriasique dans les registres : une revue systématique de la littérature portant sur 27 registres ou 16 183 patients (2020) (0)
- Les déterminants des troubles du sommeil dans le rhumatisme psoriasique : étude observationnelle portant sur 696 patients de 14 pays (2021) (0)
- Évaluation des compétences de sécurité des patients vis à vis des biothérapies et inhibiteurs de JAK: actualisation du questionnaire BioSecure (2021) (0)
- FRI0215 Fatigue in Egyptian Patients with Rheumatic Diseases; A Difficult Concept but A Major Impact: A Qualitative Study (2014) (0)
- Étude transversale des compétences de sécurité de 677 patients traités par biomédicament pour un rhumatisme inflammatoire (2015) (0)
- Amélioration de la productivité au travail chez des patients atteints de rhumatisme psoriasique après un traitement par ustékinumab et anti-TNF : données à 3 ans de l’étude PsABio (2021) (0)
- Pourquoi est-il difficile de démontrer l'efficacité des traitements non médicamenteux dans la prise en charge de la polyarthrite rhumatoïde ? (2006) (0)
- La mesure de l'interligne articulaire est un meilleur indice structural dans la gonarthrose que les scores semi-quantitatifs : étude comparative de 3 méthodes d'évaluation de l'arthrose dans 1759 radiographies. Groupe de travail OARSI-OMERACT (2007) (0)
- Le bimékizumab chez des patients atteints de rhumatisme psoriasique et présentant une réponse inadéquate aux anti-TNF : évaluation de l’efficacité et de la tolérance à 16 semaines dans une étude de phase III (2022) (0)
- Nouvelles recommandations du GRAPPA et de l’EULAR pour la prise en charge du rhumatisme psoriasique: similitudes et différences (2023) (0)
- Les barrières et facilitateurs sont corrélés au niveau d’activité physique chez les patients atteints de polyarthrite rhumatoïde ou de spondyloarthrite : une étude transversale portant sur 150 patients (2021) (0)
- Caractéristiques cliniques des douleurs de la paroi antérieure du thorax lors de la spondylarthrite : une analyse sur 275 patients ☆ (2012) (0)
- La fatigue au cours de la spondyloarthrite axiale débutante. Résultats de la cohorte française DESIR (2017) (0)
- Improvement in patient-reported outcomes in rheumatoid arthritis patients treated with sarilumab is independent of the cognition levels. (2022) (0)
- L’auto-évaluation de la maladie dans la polyarthrite rhumatoïde (PR) par l’auto-DAS28 est-elle acceptable au long cours ? Suivi à 3 ans d’un programme réalisé par des infirmiers (COMEDRA) chez 771 patients atteints de PR établie (2016) (0)
- L’activité physique diminue significativement mais modérément en cas de poussée de polyarthrite rhumatoïde ou de spondylarthrite axiale : une étude longitudinale de 170 patients utilisant un bracelet connecté (2016) (0)
- La moitié de vos patients atteints de polyarthrite rhumatoïde ne prennent pas le traitement que vous leur avez prescrit : pourquoi ? Comment y remédier ? (2007) (0)
- Quels sont les facteurs associés à la fatigue chez les patients suivis pour une polyarthrite rhumatoïde dans la cohorte COMEDRA (2016) (0)
- Devenir des traitements concomitants après initiation d'un traitement par anti-TNF alpha et possibilité de réduction de dose des anti-TNF alpha dans la polyarthrite rhumatoïde en pratique clinique (2007) (0)
- Le bimékizumab réduit fatigue et douleur chez les patients atteints de rhumatisme psoriasique actif, naïfs de biologiques ou avec réponse inadéquate (RI) aux anti-TNF : résultats à 16 semaines de 2 études de phase III randomisées, contrôlées par placebo (2022) (0)
- Définitions quantifiables des recommandations de prise en charge de la spondylarthrite ankylosante sont nécessaires pour leur utilisation dans des études observationnelles (2016) (0)
- Le bimékizumab chez des patients atteints de rhumatisme psoriasique et naïfs de biologique : évaluation de l’efficacité et de la tolérance à 24 semaines dans une étude de phase III (2022) (0)
- L’inflammation des sacro-iliaques à l’imagerie par résonnance magnétique est-elle toujours synonyme de spondyloarthrite axiale? (2022) (0)
- FRI0642-HPR BARRIERS AND FACILITATORS FOR PHYSICAL ACTIVITY ARE MAINLY RELATED TO PSYCHOLOGICAL ISSUES IN INFLAMMATORY ARTHRITIS – A MIXED-METHODS STUDY OF 66 PATIENTS IN FRANCE. (2020) (0)
- Indices et critères : quelle place en rhumatologie ? (2010) (0)
- Lu.131L'analyse cinématique de la marche comme critère de suivi dans l'arthrose des membres inférieurs : analyse systématique de la littérature (2007) (0)
- Modeste utilité de l’échodoppler des artères temporales pour le diagnostic de maladie de Horton : résultats d’une évaluation rétrospective monocentrique (2009) (0)
- Comparaison de l’efficacité de l’ustékinumab (UST) ou des anti-TNFa chez des patients atteints de rhumatisme psoriasique (RP) dans l’étude multipays en vraie vie PsABio: suivi à 12 mois (2020) (0)
- P.163 Au cours de la spondylarthrite ankylosante (SPA), l’utilisation d’un anti-TNFα est-elle associée à une toxicité moindre des anti-inflammatoires non stéroïdiens (AINS) au niveau de l’intestin grêle ? (2009) (0)
- Big data et analyses par intelligence artificielle: Les données de grande ampleur vont-elles modifier notre pratique? (2020) (0)
- Les patients atteints de rhumatisme psoriasique sont-ils traités de manière optimale autour du monde ? Disparités entre pays dans le rhumatisme psoriasique : une analyse de 410 patients provenant de 13 pays (2021) (0)
- Impact d’un antécédent familial de polyarthrite rhumatoïde chez les patients présentant une polyarthrite débutante : données de la cohorte ESPOIR (2020) (0)
- L'évaluation de la polyarthrite rhumatoïde dans les essais thérapeutiques reflète-t-elle ce qui est important pour nos patients : Le point de vue du patient (2007) (0)
- Les patients atteints d’arthrite inflammatoire qui adhèrent le plus au traitement ne font pas plus d’activité physique : une étude transversale de 152 patients, l’étude ImBAIA (2020) (0)
- Effet d'épargne cortisonique des anti-TNF alpha en pratique clinique dans la polyarthrite rhumatoïde (PR) : comparaison avant/après chez 110 patients (2007) (0)
- La pratique sportive, le post-partum, et d’autres facteurs influencent l’interprétation de l’IRM des sacro-iliaques dans les spondyloarthrites : revue systématique de la littérature (2022) (0)
- Comparaison chez des patients souffrant de polyarthrite rhumatoïde de l’efficacité à un an des traitements entre une prise en charge en vie réelle (effectiveness) vs. un contrôle serré (efficacy) (2011) (0)
- Lu.142Effets de l’etanercept sur le métabolisme de l’os et du cartilage des patients atteints de spondylarthropathie (SpA) (2006) (0)
- Version patient des recommandations de prise en charge de la polyarthrite rhumatoïde : une collaboration entre la Société française de rhumatologie et des associations de patients atteints de polyarthrite rhumatoïde (2015) (0)
- Le bimékizumab améliore les critères-patient dans le rhumatisme psoriasique : résultats à 48 semaines d’une étude de phase IIB et association entre les critères-patient et l’activité de la maladie (2020) (0)
- Dissémination et évaluation des recommandations ASAS/EULAR pour la prise en charge de la Spondylarthrite Ankylosante (SA) : résultats d'une étude chez 1,507 rhumatologues (2007) (0)
- Impact du rhumatisme psoriasique sur la qualité de vie (2020) (0)
- Plus de 40 % des femmes atteintes de PR présentent un délai de conception supérieur à 1 an : analyse de la cohorte prospective GR2 (2021) (0)
- Prévalence et évaluation de l’impact du psoriasis sur l’évolution naturelle de la coxarthrose. Résultats d’un suivi sur dix ans de 507 patients (étude Echodiah)☆ (2009) (0)
- Sensibilité et spécificité des critères de l'American College of Rheumatology 1987 pour le diagnostic de polyarthrite rhumatoïde (PR): une revue systématique de la littérature regroupant 7438 patients (2007) (0)
- Utilisation du rituximab dans la polyarthrite rhumatoïde en pratique courante : étude observationnelle de 50 cas (2007) (0)
- Élaboration et validation psychométrique d’un outil d’évaluation des craintes perçues par les patients souffrant de rhumatisme inflammatoire chronique : l’échelle « FAIR » (2016) (0)
- 27038 Efficacy of guselkumab using composite endpoints in patients with active psoriatic arthritis: Domain-specific efficacy from DISCOVER-1 and DISCOVER-2 phase 3 trials (2021) (0)
- Actualisation 2022 des Recommandations de la Société Française de Rhumatologie (SFR) pour la prise en charge en pratique courante des malades atteints de spondyloarthrite, incluant le rhumatisme psoriasique (2022) (0)
- Place de l’enthésite dans le diagnostic et le suivi de la spondyloarthrite axiale et du rhumatisme psoriasique (2023) (0)
- Développement et validation préliminaire d’un questionnaire évaluant les barrières et facilitateurs à l’activité physique chez 63 patients atteints de polyarthrite rhumatoïde, de spondyloarthrite ou de rhumatisme psoriasique (2020) (0)
- Upadacitinib en monothérapie et en association avec des DMARDs non biologiques pour le traitement du rhumatisme psoriasique : analyse en sous-groupes de deux essais de phase 3 (2020) (0)
- AB1019 Is The Self-Assessment of Disease Activity (auto-DAS28) by Patients A Feasible and Acceptable Measure over The Long Term in Rheumatoid Arthritis (RA)? Three-Year Follow-up of A Nurse-Led Program in 771 Patients with Established RA (2016) (0)
- Le traitement par AINS en préconceptionnel est significativement associé à un allongement du délai conceptionnel chez les femmes atteintes de spondyloarthrite : analyse de la cohorte prospective GR2 (2021) (0)
- Élaboration d’un auto-questionnaire « comorbidités » destiné aux patients ayant un rhumatisme inflammatoire chronique : un projet issu des Rencontres d’Experts en Rhumatologie 2015☆ (2016) (0)
- Le sarilumab améliore les critères patient au cours de la polyarthrite rhumatoïde : résultats de l’étude sariPRO (2020) (0)
- Amélioration de la communication médecin-patient dans la PR par l’usage d’un service e-santé d’auto-suivi et d’auto-mesure sur internet. Résultats de l’étude randomisée CARNet (2016) (0)
- Élaboration d’un auto-questionnaire « comorbidités » destiné aux patients ayant un rhumatisme inflammatoire chronique : un projet issu des Rencontres d’Experts en Rhumatologie 2015 (2018) (0)
- Recours à la Prothèse Totale de Hanche (PTH) après traitement par la diacéréine dans la coxarthrose: cinq ans de suivi après les 3 années de l'étude contre placebo (ECHODIAH) (2007) (0)
- La prévalence du psoriasis cutané est élevée dans plusieurs conditions rhumatologiques en France: une étude transversale de 1677 patients (2007) (0)
- L’amélioration des paramètres rapportés par les patients atteints de polyarthrite rhumatoïde traités par sarilumab est indépendante des niveaux cognitifs (2022) (0)
- le point sur… - IRM et spondylarthropathie (2010) (0)
- Risque d'infections sévères au cours des traitements par rituximab, abatacept et anakinra chez des patients atteints de polyarthrite rhumatoïde: analyse systématique de la littérature et méta-analyse (2006) (0)
- Mortalité dans la polyarthrite rhumatoïde au cours des 50 dernières années : revue systématique et méta-analyse ☆ (2013) (0)
- Efficacité d’upadacitinib chez des patients atteints de rhumatisme psoriasique actif ayant un nombre d’articulations gonflées élevé ou faible : analyse de sous-groupes de 2 études de phase 3 (SELECT-PsA 1 et SELECT-PsA 2) (2021) (0)
- Iconography : le point sur… - IRM du rachis et des articulations sacro-iliaques dans la spondylarthrite ankylosante (2010) (0)
- Development and validation of a self-administered questionnaire measuring essential knowledge in patients with rheumatoid arthritis (2022) (0)
- Connaissances et attentes des programmes de réentraînement à l’effort chez les patients lombalgiques chroniques : étude miroir chez 150 patients et 80 médecins en 2017 (2020) (0)
- Iconographies supplémentaires de l'article : le point sur… - IRM et spondylarthropathie (2010) (0)
- Améliorer le consensus autour de l’évaluation de la synovite dans la polyarthrite rhumatoïde (2013) (0)
- L’impact du rhumatisme psoriasique est plus important et la durée de maintien du traitement plus courte chez les femmes que chez les hommes traités par ustékinumab et par anti-TNF : données à un an de l’étude PsABio (2021) (0)
- Utilisabilité d’objets connectés en recherche clinique et épidémiologique : résultats d’une étude multicentrique française sur 177 patients en rhumatologie (2017) (0)
- Le Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), largement utilisé dans la spondyloarthrite, est-il influencé par l’optimisme des patients ? Une étude transversale de 206 patients☆ (2017) (0)
- Le psoriasis est fréquent dans une population de patients atteints de coxarthrose. Suivi à 10 ans de la cohorte ECHODIAH (2007) (0)
- Valeur diagnostique de l’IRM et de l’echographie-doppler puissance des talons au cours de la spondylarthropathie (2009) (0)
- Effet taille des traitements médicamenteux sur l'atteinte périphérique des spondylarthrites ankylosantes : revue systématique de la littérature (2007) (0)
- THU0353 Development and Validation of a Questionnaire Assessing the Fears and Beliefs of Patients Suffering from Chronic Rheumatic Diseases (2015) (0)
- Effet des traitements biologiques sur la fatigue dans le rhumatisme psoriasique : revue systématique de la littérature et méta-analyse (2019) (0)
- Facteurs associés à la connaissance générale et à celle des éléments de sécurité des patients sous biothérapie pour un rhumatisme inflammatoire : étude de 677 patients (2018) (0)
- Un tiers des patients atteints de polyarthrite rhumatoïde (PR) établie sont correctement vaccinés contre la grippe et le pneumocoque et cette proportion augmente : évaluation longitudinale sur 3 ans des 769 patients de l’étude COMEDRA (2016) (0)
- Freins et croyances en rhumatologie dans la pratique de l’activité physique (2021) (0)
- Residual patient-reported burden in 444 patients with psoriatic arthritis in remission or low disease: a cross-sectional analysis. (2022) (0)
- THU0686 Changes in health-related quality of life over 5 to 8 years in 1347 patients with early arthritis or early inflammatory back pain (2018) (0)
- OP0153 PRECONCEPTIONAL NSAID TREATMENT IS ASSOCIATED WITH LONGER TIME-TO-CONCEPTION IN WOMEN WITH SPONDYLOARTHRITIS: ANALYSIS OF THE PROSPECTIVE GR2 COHORT (2022) (0)
- POS0055 SARS-COV-2 OUTBREAK IN AUTOIMMUNE DISEASES: THE EURO-COVIMID STUDY (2021) (0)
- P61 SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry (2022) (0)
- SP0044 Screening for comorbidities in daily practice: who and how? (2017) (0)
- I-8 OARSI-OMERACT SET OF CRITERIA IN KNEE/HIP OSTEOARTHRITIS TO BE USED AS A HARD ENDPOINT IN CLINICAL TRIALS EVALUATING POTENTIAL DISEASE-MODIFYING DRUGS (2008) (0)
- SAT0398 Fatigue in Psoriatic Arthritis is Related to Disease Activity Rather than to Demographic Characteristics – an Ancillary Analysis of the Cross-Sectional International PSAID Study of 246 Patients (2014) (0)
- Overtreatment in rheumatoid arthritis: are there reasons for concern? (2022) (0)
- 1 Performance of Patient Reported Outcomes in the assessment of rheumatoid arthritis disease activity : The experience of the ESPOIR cohort Running title : Disease activity by patient reported outcomes (0)
- Nurse-Guided Completion of the BASDAI Questionnaire in Ankylosing Spondylitis Patients with Low Literacy (2010) (0)
- OP0268-PARE Patients as Partners in Research: Practical Guidelines to Optimize Collaboration (2013) (0)
- 169 Secukinumab provides sustained reduction in fatigue in patients with active psoriatic arthritis through three years: long-term data from the FUTURE 1 and FUTURE 2 studies (2018) (0)
- SAT0691 Adherence to disease-modifying drugs in chronic inflammatory rheumatic diseases: several questionnaires, diverse patient characteristics and some efficacious interventions – a systematic literature review (2018) (0)
- The Journal of Rheumatology MethodologyInstrument Selection Using the OMERACT Filter 2.1: The OMERACT (2020) (0)
- FRI0631 Workforce requirements in rheumatology: a systematic literature review informing the development of a workforce prediction quality appraisal tool (2018) (0)
- THU0536 Knowledge of and expectations about functional restoration program for chronic low back pain are often false: a mirror survey of 40 patients and 59 physicians in 2017 (2018) (0)
- PsABIOnd Study and eDaily Substudy Design: Long-Term Effectiveness and Safety of Guselkumab and IL-17 Inhibitors in Routine Clinical Practice in Patients with Psoriatic Arthritis (2022) (0)
- SAT0112 Prevalence and incidence over 3 years of different comorbidities in rheumatoid arthritis (RA): a 3 year longitudinal study in 769 established ra patients (2017) (0)
- Le délai diagnostique de la spondyloarthrite axiale : étude transversale sur 432 patients (2017) (0)
- Can We Harmonize Them? An OMERACT Collaborative Initiative Outcome Domains and Measures in Total Joint Replacement Clinical Trials: (2015) (0)
- Acceptation par les rhumatologues des recommandations pour la prise en charge en pratique courante des personnes atteintes de polyarthrite rhumatoïde (2005) (0)
- FRI0600 Fears and Beliefs of People Living with Rheumatoid Arthritis, Ankylosing Spondylitis or Psoriatic Arthritis: A Systematic Literature Review (2016) (0)
- Uvéites au cours des spondylarthropathies: analyse systématique de la littérature (2006) (0)
- Les patients PR sont-ils enclins à utiliser un service e-santé d’auto-suivi et d’auto-mesure sur internet ? Sous-analyse de l’étude randomisée CARNet (2016) (0)
- THU0589 Patient-perceived coping was associated with patient-perceived quality of patient-physician interactions in 320 patients with rheumatoid arthritis (2017) (0)
- Influence du « flare design » sur l'efficacité des AINS dans l'arthrose : méta-analyse des essais randomisés contrôlés contre placebo (2007) (0)
- SAT0329 IMPACT OF AXIAL SPONDYOARTHRITIS (AXSPA) ON SOCIAL AND FAMILY LIFE: RESULTS OF THE EMAS SURVEY OF 638 PATIENTS IN 2018 (2019) (0)
- The adherence questionnaires in chronic inflammatory rheumatic diseases and their psychometric properties: a systematic literature review. (2021) (0)
- THU0334 Functional Restoration Programs for Chronic Low Back Pain Patients are not Just a Sports Facility! Change in Muscle (OR LEAN) Mass Assessed through DXA in 95 Patients, A Monocentric Study (2014) (0)
- U-06 Infections sur prothèses articulaires et anti-TNFα (2008) (0)
- FRI0074 Renal Dysfunction in Patients with Rheumatoid Arthritis: Results from the Comedra Study (2014) (0)
- THU0006 Combinatorial control of TH1 and TH17 cell functions by single-nucleotide polymorphisms at genes associated with the IL-23 signaling pathway in spondyloarthritis (2013) (0)
- THU0357 No specific impact of concomitant fibromyalgia on the anti tnf treatment effect in axial spondyloarthritis patients without radiographic structural damage or objective signs of inflammation (2017) (0)
- SP0197 Making Mentoring Effective – The View of the Mentor (2013) (0)
- Rheumatoid Arthritis Impact of Disease Questionnaire (2020) (0)
- Patient–Physician Alignment in Satisfaction With Psoriatic Arthritis Treatment: Analysis From a Cross-Sectional Survey in the United States and Europe (2020) (0)
- Introduction (2015) (0)
- French Early Arthritis Cohort ESPOIR Investigations in Early Arthritis on the Diagnosis of Rheumatoid Arthritis (2010) (0)
- THU0063 Does biologic treatment modify the relationship of the variables associated with fatigue in patients with rheumatoid arthritis? The peps study of tocilizumab in real life (2013) (0)
- Effect of Fatigue on Health-Related Quality of Life and Work Productivity in Psoriatic Arthritis: Findings From a Real-World Survey (2022) (0)
- SAT0378 DRIVERS OF DISCORDANCE IN PSORIATIC ARTHRITIS WHEN ANALYZING THE LINK BETWEEN PATIENT-PERCEIVED GOOD STATUS AND THE DISEASE ACTIVITY IN PSORIATIC ARTHRITIS (DAPSA) COMPOSITE SCORE: AN ANALYSIS OF 436 PATIENTS FROM THE INTERNATIONAL REFLAP OBSERVATIONAL STUDY (2019) (0)
- Les dimensions vertébrales sont un facteur de risque indépendant de fracture vertébrale chez les hommes et les femmes âgés : revue systématique de la littérature (2006) (0)
- High Levels Of Fears Of Patients With Rheumatoid Arthritis Or Axial Spondyloarthritis Are Associated With Gender, Disease Activity, Anxiety And Depression: A Cross-Sectional Study Of 672 Patients (2016) (0)
- AB0772 Secukinumab provides sustained improvement in function, quality of life and fatigue over 2 years in patients who achieved low disease activity related to psoriatic arthritis disease activity score (PASDAS) (2017) (0)
- OP0242 Health-related quality of life improved only slightly although disease activity decreased over 3 years in early axial spondyloarthritis: 442 patients from the desir cohort (2017) (0)
- Fluctuation of pain is frequent in rheumatoid arthritis and axial spondyloarthritis: a 12 weeks prospective study of 165 patients. (2021) (0)
- AB0947 Are X-Rays the Adequate Imaging Modality for Structural Damage Assessment of the Sacro-Iliac Joints? Comparative Study of 29 Spondyloarthritis Patients with Structural Damage of the Sacroiliac Joints and 48 Controls (2014) (0)
- POS0004 WHAT DOES WORSENING IN DAPSA DISEASE ACTIVITY CATEGORIES MEAN FOR PATIENTS WITH PSORIATIC ARTHRITIS? AN ANALYSIS OF 222 PATIENTS (2022) (0)
- trial and ESPOIR cohort rheumatoid arthritis : data from the GUEPARD activeroutine care in patients with recent-onset Disease activity score-driven therapy versus (2011) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Laure Gossec?
Laure Gossec is affiliated with the following schools:
